31108759;2019 Jul;na;diabetes (type 2) AND Momordica charantia;Fermented Momordica charantia L. juice modulates hyperglycemia, lipid profile, and gut microbiota in type 2 diabetic rats.
31059755;2019 May 3;na;diabetes (type 2) AND Momordica charantia;Susceptibility of poultry associated bacterial pathogens to Momordica charantia fruits and evaluation of in vitro biological properties.
31005847;2019 Mar 23;na;diabetes (type 2) AND Momordica charantia;Momordica charantia (bitter melon) modulates adipose tissue inflammasome gene expression and adipose-gut inflammatory cross talk in high-fat diet (HFD)-fed mice.
30902279;2019 Aug 1;na;diabetes (type 2) AND Momordica charantia;Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.
30661947;2019 Jan 17;na;diabetes (type 2) AND Momordica charantia;Ayurvedic polyherbal combination (PDBT) for prediabetes: A randomized double blind placebo controlled study.
30551527;2019 Jan;na;diabetes (type 2) AND Momordica charantia;Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
30442186;2018 Nov 15;na;diabetes (type 2) AND Momordica charantia;Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.
30386403;2018;na;diabetes (type 2) AND Momordica charantia;Antihyperglycemic and Antilipidemic Effects of the Ethanol Extract Mixture of Ligularia fischeri and Momordica charantia in Type II Diabetes-Mimicking Mice.
30385422;2019 Mar 1;na;diabetes (type 2) AND Momordica charantia;Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.
30241862;2018 Dec 1;na;diabetes (type 2) AND Momordica charantia;Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats.
30180967;2018 Oct 30;na;diabetes (type 2) AND Momordica charantia;Transcriptomic analysis of Momordica charantia polysaccharide on streptozotocin-induced diabetic rats.
29884151;2018 Jun 8;na;diabetes (type 2) AND Momordica charantia;Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka.
29655677;2018 Mar 15;na;diabetes (type 2) AND Momordica charantia;An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
29431598;2018 Jul;na;diabetes (type 2) AND Momordica charantia;Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus.
29405623;2018 Apr;na;diabetes (type 2) AND Momordica charantia;Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice.
29317893;2017;na;diabetes (type 2) AND Momordica charantia;Effectiveness of Antihyperglycemic Effect of Momordica charantia: Implication of T-Cell Cytokines.
29217884;2017 Nov-Dec;na;diabetes (type 2) AND Momordica charantia;How Harmful Can Herbal Remedies Be? A Case of Severe Acute Tubulointerstitial Nephritis.
29164155;2017;na;diabetes (type 2) AND Momordica charantia;New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis.
29110587;2017 Dec;na;diabetes (type 2) AND Momordica charantia;Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats.
28812026;2017;na;diabetes (type 2) AND Momordica charantia;Evidence of Immunosuppressive and Th2 Immune Polarizing Effects of Antidiabetic Momordica charantia Fruit Juice.
28729836;2017;na;diabetes (type 2) AND Momordica charantia;An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes.
28623919;2017 Jun 17;na;diabetes (type 2) AND Momordica charantia;Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study.
28335529;2017 Mar 20;na;diabetes (type 2) AND Momordica charantia;Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium.
28120728;2017;na;diabetes (type 2) AND Momordica charantia;Momordicacharantia: A New Strategic Vision to Improve the Therapy of Endoplasmic Reticulum Stress.
28064559;2017 Dec;na;diabetes (type 2) AND Momordica charantia;Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.
27751827;2016 Dec 24;na;diabetes (type 2) AND Momordica charantia;Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats.
27352776;2016 Sep;na;diabetes (type 2) AND Momordica charantia;Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats.
27190792;2016 Apr;na;diabetes (type 2) AND Momordica charantia;Evaluation of Protein Kinase Cbeta and PPARgamma Activity in Diabetic Rats Supplemented with Momordica charantia.
26459126;2015 Sep;na;diabetes (type 2) AND Momordica charantia;[Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus III. Momordica (Momordica charantia)].
26456213;2016;na;diabetes (type 2) AND Momordica charantia;Oral Delivery of Antidiabetic Polypeptide-k: Journey so far and the Road Ahead.
26401401;2015 Apr-Jun;na;diabetes (type 2) AND Momordica charantia;Use of household ingredients as complementary medicines for perceived hypoglycemic benefit among Sri Lankan diabetic patients; a cross-sectional survey.
26325432;2015 Nov 4;na;diabetes (type 2) AND Momordica charantia;Traditional plants used for the treatment of diabetes mellitus in Sursagar constituency, Jodhpur, Rajasthan - An ethnomedicinal survey.
26088353;2015;na;diabetes (type 2) AND Momordica charantia;Tetracyclic triterpenoids in herbal medicines and their activities in diabetes and its complications.
26045386;2014 Nov;na;diabetes (type 2) AND Momordica charantia;Biochemical analysis of the crude extract of Momordica charantia (L.).
25623883;2015 Jan 26;na;diabetes (type 2) AND Momordica charantia;Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.
25488547;2015 Mar;na;diabetes (type 2) AND Momordica charantia;Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-kappaB and JNK pathways in high-fat-fed OLETF rats.
25331834;2014 Oct 21;na;diabetes (type 2) AND Momordica charantia;The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective?
24836069;2014 Jun 23;na;diabetes (type 2) AND Momordica charantia;New compounds from acid hydrolyzed products of the fruits of Momordica charantia L. and their inhibitory activity against protein tyrosine phosphatas 1B.
24751968;2014 Jul;na;diabetes (type 2) AND Momordica charantia;Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
24672797;2014;na;diabetes (type 2) AND Momordica charantia;Effects of Momordica charantia L. on the blood rheological properties in diabetic patients.
24360831;2014 Jan 15;na;diabetes (type 2) AND Momordica charantia;Honokiol trimers and dimers via biotransformation catalyzed by Momordica charantia peroxidase: novel and potent alpha-glucosidase inhibitors.
24358329;2013;na;diabetes (type 2) AND Momordica charantia;Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues.
24295371;2014 Jan;na;diabetes (type 2) AND Momordica charantia;Momordica charantia and type 2 diabetes: from in vitro to human studies.
23802882;2013 Jun 26;na;diabetes (type 2) AND Momordica charantia;Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia.
23411283;2013 Jun 1;na;diabetes (type 2) AND Momordica charantia;Biguanide related compounds in traditional antidiabetic functional foods.
22895968;2012 Aug 15;na;diabetes (type 2) AND Momordica charantia;Momordica charantia for type 2 diabetes mellitus.
22683870;2012 Aug 15;na;diabetes (type 2) AND Momordica charantia;EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-alpha-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner.
25767500;2012 Jan 25;na;diabetes (type 2) AND Momordica charantia;Protective effects of Purendan superfine powder on retinal neuron apoptosis in a rat model of type 2 diabetes mellitus.
22182422;2012 Sep 28;na;diabetes (type 2) AND Momordica charantia;Antioxidant and anti-inflammatory effect of conjugated linolenic acid isomers against streptozotocin-induced diabetes.
22001161;2012 Jan;na;diabetes (type 2) AND Momordica charantia;Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11beta-hydroxysteroid dehydrogenase type 1 inhibitor.
21966327;2011;na;diabetes (type 2) AND Momordica charantia;Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.
21794176;2011 Jul 28;na;diabetes (type 2) AND Momordica charantia;Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.
21328131;2011 Feb;na;diabetes (type 2) AND Momordica charantia;Modulation of pancreatic beta-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp.
21211558;2011 Mar 24;na;diabetes (type 2) AND Momordica charantia;Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
21205111;2011 Apr;na;diabetes (type 2) AND Momordica charantia;Diabetes is an inflammatory disease: evidence from traditional Chinese medicines.
20615270;2010 Dec;na;diabetes (type 2) AND Momordica charantia;Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice.
20587058;2010 Jun 29;na;diabetes (type 2) AND Momordica charantia;Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes.
20166099;2010 Feb 17;na;diabetes (type 2) AND Momordica charantia;Momordica charantia for type 2 diabetes mellitus.
19825210;2009 Dec;na;diabetes (type 2) AND Momordica charantia;Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
19509199;2009 Jun;na;diabetes (type 2) AND Momordica charantia;Complementary and alternative medicine for the treatment of type 2 diabetes.
19362455;2009 May;na;diabetes (type 2) AND Momordica charantia;Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
18656931;2008 Aug 27;na;diabetes (type 2) AND Momordica charantia;A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase.
18537692;2008 Jun;na;diabetes (type 2) AND Momordica charantia;Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans.
18024034;2008 Jan 17;na;diabetes (type 2) AND Momordica charantia;Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
17493509;2007 Jun;na;diabetes (type 2) AND Momordica charantia;The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
17484443;2007 Apr;na;diabetes (type 2) AND Momordica charantia;[Unconventional antidiabetic agents].
17117226;2006 Sep-Oct;na;diabetes (type 2) AND Momordica charantia;Hypoglycaemic and hypotensive effects of Momordica charantia Linn (Cucurbitaceae) whole-plant aqueous extract in rats.
16719780;2006;na;diabetes (type 2) AND Momordica charantia;Antidiabetic agents from medicinal plants.
16111053;2005 May;na;diabetes (type 2) AND Momordica charantia;[The hypoglycemic effects of crude polysaccharides extract from Momordica charantia in mice].
15521566;2004 Apr;na;diabetes (type 2) AND Momordica charantia;Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM).
15236800;2004;na;diabetes (type 2) AND Momordica charantia;Does bitter melon contain an activator of AMP-activated kinase?
15234774;2004 Aug;na;diabetes (type 2) AND Momordica charantia;Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity.
15165418;2004 Apr;na;diabetes (type 2) AND Momordica charantia;Role of selected Indian plants in management of type 2 diabetes: a review.
14974734;2003 Dec;na;diabetes (type 2) AND Momordica charantia;Bitter melon malt vinegar increases daily energy turnover in rats.
14758046;2004 Feb;na;diabetes (type 2) AND Momordica charantia;Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice.
14748342;2002 Mar;na;diabetes (type 2) AND Momordica charantia;[Advances in the study of Momordica charantia L].
14723327;2003 Jul;na;diabetes (type 2) AND Momordica charantia;Evaluation of the efficacy of bitter gourd (momordica charantia) as an oral hypoglycemic agent--a randomized controlled clinical trial.
12663610;2003 Apr;na;diabetes (type 2) AND Momordica charantia;Systematic review of herbs and dietary supplements for glycemic control in diabetes.
12625217;2003 Feb 15;na;diabetes (type 2) AND Momordica charantia;Bitter melon (Momordica charantia): a review of efficacy and safety.
11814149;2001 Oct;na;diabetes (type 2) AND Momordica charantia;Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice.
10758656;1999 Apr;na;diabetes (type 2) AND Momordica charantia;Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients.
8255932;1993 Oct;na;diabetes (type 2) AND Momordica charantia;Studies on hypoglycemic effects of fruit pulp, seed, and whole plant of Momordica charantia on normal and diabetic model rats.
3446597;1987 Aug;na;diabetes (type 2) AND Momordica charantia;Retardation of retinopathy by Momordica charantia L. (bitter gourd) fruit extract in alloxan diabetic rats.
3807390;1986 Sep;na;diabetes (type 2) AND Momordica charantia;Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.
7334382;1981 Nov-Dec;na;diabetes (type 2) AND Momordica charantia;Hypoglycemic activity of polypeptide-p from a plant source.
30790347;2019 Feb 20;na;blood sugar AND Momordica charantia;Possible molecular mechanisms of glucose-lowering activities of Momordica charantia (karela) in diabetes.
30661947;2019 Jan 17;na;blood sugar AND Momordica charantia;Ayurvedic polyherbal combination (PDBT) for prediabetes: A randomized double blind placebo controlled study.
30627515;2018;na;blood sugar AND Momordica charantia;Nephrotoxicity and highly active antiretroviral therapy: Mitigating action of Momordica charantia.
30551527;2019 Jan;na;blood sugar AND Momordica charantia;Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
30532795;2018;na;blood sugar AND Momordica charantia;Effect of Bitter Melon Extracts on Lipid Levels in Japanese Subjects: A Randomized Controlled Study.
30442186;2018 Nov 15;na;blood sugar AND Momordica charantia;Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.
30400958;2018 Nov 6;na;blood sugar AND Momordica charantia;Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation.
30391593;2019 Feb 1;na;blood sugar AND Momordica charantia;Preparation of a Momordica charantia L. polysaccharidechromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes.
30057048;2018 Aug;na;blood sugar AND Momordica charantia;The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
29884151;2018 Jun 8;na;blood sugar AND Momordica charantia;Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka.
29776414;2018 May 18;na;blood sugar AND Momordica charantia;GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.
29655677;2018 Mar 15;na;blood sugar AND Momordica charantia;An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
29431598;2018 Jul;na;blood sugar AND Momordica charantia;Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus.
29405623;2018 Apr;na;blood sugar AND Momordica charantia;Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice.
29339109;2018 Apr 24;na;blood sugar AND Momordica charantia;Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania.
29317893;2017;na;blood sugar AND Momordica charantia;Effectiveness of Antihyperglycemic Effect of Momordica charantia: Implication of T-Cell Cytokines.
29126447;2017 Nov 10;na;blood sugar AND Momordica charantia;Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia).
29110587;2017 Dec;na;blood sugar AND Momordica charantia;Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats.
28994284;2017 Oct 25;na;blood sugar AND Momordica charantia;Gastro-Resistant Insulin Receptor-Binding Peptide from Momordica charantia Improved the Glucose Tolerance in Streptozotocin-Induced Diabetic Mice via Insulin Receptor Signaling Pathway.
28729836;2017;na;blood sugar AND Momordica charantia;An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes.
28458274;2017 Jun 29;na;blood sugar AND Momordica charantia;Supplementation with Hualian No. 4 wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) extract increases anti-fatigue activities and enhances exercise performance in mice.
28335529;2017 Mar 20;na;blood sugar AND Momordica charantia;Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium.
28092345;2017 Jan 16;na;blood sugar AND Momordica charantia;Acute effects of a beverage containing bitter melon extract (CARELA) on postprandial glycemia among prediabetic adults.
27984270;2017 Jan;na;blood sugar AND Momordica charantia;Bitter Melon Extract Promotes Granulation Tissue Growth and Angiogenesis in the Diabetic Wound.
27748816;2016 Nov;na;blood sugar AND Momordica charantia;Antidiabetic activities of a cucurbitanetype triterpenoid compound from Momordica charantia in alloxaninduced diabetic mice.
27751827;2016 Dec 24;na;blood sugar AND Momordica charantia;Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats.
27731809;2016 Sep;na;blood sugar AND Momordica charantia;Hypoglycemic and hypolipidemic effects of Lactobacillus fermentum, fruit extracts of Syzygium cumini and Momordica charantia on diabetes induced mice.
27538854;2016 Dec;na;blood sugar AND Momordica charantia;(1)H NMR-based metabolic study reveals the improvements of bitter melon (Momordica charantia) on energy metabolism in diet-induced obese mouse.
27454418;2016 Jul 18;na;blood sugar AND Momordica charantia;In vitro and in vivo alpha-amylase and alpha-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
27352776;2016 Sep;na;blood sugar AND Momordica charantia;Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats.
28959571;2016;na;blood sugar AND Momordica charantia;Safety assessment of McB-E60 (extract of a Momordica sp.): Subchronic toxicity study in rats.
27190792;2016 Apr;na;blood sugar AND Momordica charantia;Evaluation of Protein Kinase Cbeta and PPARgamma Activity in Diabetic Rats Supplemented with Momordica charantia.
26988505;2016 Aug 1;na;blood sugar AND Momordica charantia;Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein.
26624580;2015 Sep;na;blood sugar AND Momordica charantia;Investigation of the Blood Glucose Lowering Potential of the Jamaican Momordica charantia (Cerasee) Fruit in Sprague-Dawley Rats.
26459126;2015 Sep;na;blood sugar AND Momordica charantia;[Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus III. Momordica (Momordica charantia)].
26318666;2015 Nov;na;blood sugar AND Momordica charantia;Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice.
25778708;2015 Apr 21;na;blood sugar AND Momordica charantia;Design, synthesis and biological evaluation of novel peptide MC2 analogues from Momordica charantia as potential anti-diabetic agents.
25623883;2015 Jan 26;na;blood sugar AND Momordica charantia;Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.
25542240;2015 Mar;na;blood sugar AND Momordica charantia;Momordica charantia seed lectin: toxicity, bacterial agglutination and antitumor properties.
25520930;2014;na;blood sugar AND Momordica charantia;Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis.
25371774;2014;na;blood sugar AND Momordica charantia;Protective effect of Momordica charantia fruit extract on hyperglycaemia-induced cardiac fibrosis.
25164446;2014;na;blood sugar AND Momordica charantia;Effectiveness of traditional Malaysian vegetables (ulam) in modulating blood glucose levels.
25153878;2014 Aug 21;na;blood sugar AND Momordica charantia;Anti-inflammatory effect of Momordica charantia in sepsis mice.
25144709;2014 Sep 10;na;blood sugar AND Momordica charantia;A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway.
24940315;2013 Dec;na;blood sugar AND Momordica charantia;In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L.
24751968;2014 Jul;na;blood sugar AND Momordica charantia;Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
24566057;2014 Feb 21;na;blood sugar AND Momordica charantia;Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes.
24295371;2014 Jan;na;blood sugar AND Momordica charantia;Momordica charantia and type 2 diabetes: from in vitro to human studies.
24189525;2013 Nov 5;na;blood sugar AND Momordica charantia;Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice.
24023418;2013;na;blood sugar AND Momordica charantia;Structure modeling and antidiabetic activity of a seed protein of Momordica charantia in non-obese diabetic (NOD) mice.
23610006;2014 Mar;na;blood sugar AND Momordica charantia;Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice.
23569923;2012 Apr;na;blood sugar AND Momordica charantia;An overview on antidiabetic medicinal plants having insulin mimetic property.
23414136;2013 Mar 13;na;blood sugar AND Momordica charantia;Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor.
23320026;2012;na;blood sugar AND Momordica charantia;Comprehensive Evaluation of Anti-hyperglycemic Activity of Fractionated Momordica charantia Seed Extract in Alloxan-Induced Diabetic Rats.
23203059;2012 Nov 2;na;blood sugar AND Momordica charantia;Effect of superfine grinding on antidiabetic activity of bitter melon powder.
23071947;2011 Oct;na;blood sugar AND Momordica charantia;A novel herbal formulation in the management of diabetes.
23053765;2013 Jun;na;blood sugar AND Momordica charantia;In vitro toxicity and antidiabetic activity of a newly developed polyherbal formulation (MAC-ST/001) in streptozotocin-induced diabetic Wistar rats.
22654584;2012;na;blood sugar AND Momordica charantia;Traditional medicinal herbs and food plants have the potential to inhibit key carbohydrate hydrolyzing enzymes in vitro and reduce postprandial blood glucose peaks in vivo.
22329631;2012 Apr 1;na;blood sugar AND Momordica charantia;A review of the hypoglycemic effects of five commonly used herbal food supplements.
22297232;2012 Jan;na;blood sugar AND Momordica charantia;Synergic effects of bitter melon and beta-Glucan composition on STZ-induced rat diabetes and its complications.
23983370;2012;na;blood sugar AND Momordica charantia;Medicinal plants used for treatment of diabetes by the Marakh sect of the Garo tribe living in Mymensingh district, Bangladesh.
22133295;2011 Dec 15;na;blood sugar AND Momordica charantia;Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.
22125958;2011 Nov-Dec;na;blood sugar AND Momordica charantia;Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits.
22101446;2012 Feb;na;blood sugar AND Momordica charantia;Tandem multimer expression and preparation of hypoglycemic peptide MC6 from Momordica charantia in Escherichia coli.
21966327;2011;na;blood sugar AND Momordica charantia;Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.
21930012;2011 Oct;na;blood sugar AND Momordica charantia;Niacin-bound chromium increases life span in Zucker Fatty Rats.
21794176;2011 Jul 28;na;blood sugar AND Momordica charantia;Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.
21367579;2011 Jun;na;blood sugar AND Momordica charantia;Polyphenols: planting the seeds of treatment for the metabolic syndrome.
21328131;2011 Feb;na;blood sugar AND Momordica charantia;Modulation of pancreatic beta-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp.
21205111;2011 Apr;na;blood sugar AND Momordica charantia;Diabetes is an inflammatory disease: evidence from traditional Chinese medicines.
21174950;2010 Aug;na;blood sugar AND Momordica charantia;Anti-hyperglycemic and anti-oxidative effect of aqueous extract of Momordica charantia pulp and Trigonella foenum graecum seed in alloxan-induced diabetic rats.
21117023;2011 Jan;na;blood sugar AND Momordica charantia;Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats.
21056650;2011 Jan 27;na;blood sugar AND Momordica charantia;Neuroprotective effect of Momordica charantia in global cerebral ischemia and reperfusion induced neuronal damage in diabetic mice.
20716916;2009 Nov-Dec;na;blood sugar AND Momordica charantia;The plant extracts of Momordica charantia and Trigonella foenum-graecum have anti-oxidant and anti-hyperglycemic properties for cardiac tissue during diabetes mellitus.
20615270;2010 Dec;na;blood sugar AND Momordica charantia;Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice.
20521977;2010 Jun;na;blood sugar AND Momordica charantia;Momordica charantia maintains normal glucose levels and lipid profiles and prevents oxidative stress in diabetic rats subjected to chronic sucrose load.
19904502;2010 Apr;na;blood sugar AND Momordica charantia;Complementary and comparative study on hypoglycemic and antihyperglycemic activity of various extracts of Eugenia jambolana seed, Momordica charantia fruits, Gymnema sylvestre, and Trigonella foenum graecum seeds in rats.
19761040;2009 Jul;na;blood sugar AND Momordica charantia;Antihyperglycemic, antihyperlipidemic and antioxidant effects of Dihar, a polyherbal ayurvedic formulation in streptozotocin induced diabetic rats.
19665538;2009 Oct 29;na;blood sugar AND Momordica charantia;No effect of acute, single dose oral administration of Momordica charantia Linn., on glycemia, energy expenditure and appetite: a pilot study in non-diabetic overweight men.
19509199;2009 Jun;na;blood sugar AND Momordica charantia;Complementary and alternative medicine for the treatment of type 2 diabetes.
19429344;2009 May 4;na;blood sugar AND Momordica charantia;Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
19362455;2009 May;na;blood sugar AND Momordica charantia;Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
21304609;2009 Oct 15;na;blood sugar AND Momordica charantia;Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats.
26047444;2008 Nov 15;na;blood sugar AND Momordica charantia;Purification and characterisation of a hypoglycemic peptide from Momordica Charantia L. Var. abbreviata Ser.
18983991;2009 Feb 12;na;blood sugar AND Momordica charantia;Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats.
18855210;2008;na;blood sugar AND Momordica charantia;Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems.
18831340;2008 Jan;na;blood sugar AND Momordica charantia;Effects of alcoholic extract of Momordica charantia (Linn.) whole fruit powder on the pancreatic islets of alloxan diabetic albino rats.
18800899;2008 Sep;na;blood sugar AND Momordica charantia;Effect of Indian herbal hypoglycemic agents on antioxidant capacity and trace elements content in diabetic rats.
18550200;2008 Aug;na;blood sugar AND Momordica charantia;Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet.
18537696;2008 Jun;na;blood sugar AND Momordica charantia;Traditional chinese medicine in treatment of metabolic syndrome.
18537692;2008 Jun;na;blood sugar AND Momordica charantia;Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans.
18321395;2008 Oct;na;blood sugar AND Momordica charantia;Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions.
18254212;2007 Dec;na;blood sugar AND Momordica charantia;Regeneration of beta cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits.
18202535;2007 Dec;na;blood sugar AND Momordica charantia;Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.
17942003;2008 Apr;na;blood sugar AND Momordica charantia;Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats.
17892543;2007 Sep 24;na;blood sugar AND Momordica charantia;An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract.
17493509;2007 Jun;na;blood sugar AND Momordica charantia;The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
17484443;2007 Apr;na;blood sugar AND Momordica charantia;[Unconventional antidiabetic agents].
17341830;2007 Mar;na;blood sugar AND Momordica charantia;Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction.
16910221;2006 Jul;na;blood sugar AND Momordica charantia;Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
16819222;2006 Jul;na;blood sugar AND Momordica charantia;Momordica charantia constituents and antidiabetic screening of the isolated major compounds.
16815658;2006 Nov 24;na;blood sugar AND Momordica charantia;Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats.
16755004;2006 Jun;na;blood sugar AND Momordica charantia;Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
16298503;2006 Apr 21;na;blood sugar AND Momordica charantia;Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats.
16251604;2005 Nov;na;blood sugar AND Momordica charantia;Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression.
16196458;2005;na;blood sugar AND Momordica charantia;Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet.
16187012;2005 Sep;na;blood sugar AND Momordica charantia;Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.
16111053;2005 May;na;blood sugar AND Momordica charantia;[The hypoglycemic effects of crude polysaccharides extract from Momordica charantia in mice].
16106394;2005 May;na;blood sugar AND Momordica charantia;Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus.
16007724;2005 Aug;na;blood sugar AND Momordica charantia;Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats.
15975176;2005 May;na;blood sugar AND Momordica charantia;Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines.
15930730;2005 Jun;na;blood sugar AND Momordica charantia;Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats.
15927932;2005;na;blood sugar AND Momordica charantia;Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats.
15918591;2005 May;na;blood sugar AND Momordica charantia;Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats.
15646680;2004 Dec 8;na;blood sugar AND Momordica charantia;[Bitter melon to control high blood sugar].
15597317;2004 Nov;na;blood sugar AND Momordica charantia;Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats.
15525451;2004 Nov;na;blood sugar AND Momordica charantia;Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocin-induced diabetic rats.
15362486;2004 Jun;na;blood sugar AND Momordica charantia;Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat.
14758046;2004 Feb;na;blood sugar AND Momordica charantia;Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice.
14758036;2004 Feb;na;blood sugar AND Momordica charantia;Momordica charantia extracts inhibit uptake of monosaccharide and amino acid across rat everted gut sacs in-vitro.
14729399;2004 Feb 6;na;blood sugar AND Momordica charantia;Tissue specific expression and immunohistochemical localization of glutathione S-transferase in streptozotocin induced diabetic rats: modulation by Momordica charantia (karela) extract.
14723327;2003 Jul;na;blood sugar AND Momordica charantia;Evaluation of the efficacy of bitter gourd (momordica charantia) as an oral hypoglycemic agent--a randomized controlled clinical trial.
12902059;2003 Sep;na;blood sugar AND Momordica charantia;Antihyperglycemic effects of three extracts from Momordica charantia.
12672924;2003 Apr;na;blood sugar AND Momordica charantia;Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet.
12663610;2003 Apr;na;blood sugar AND Momordica charantia;Systematic review of herbs and dietary supplements for glycemic control in diabetes.
12625217;2003 Feb 15;na;blood sugar AND Momordica charantia;Bitter melon (Momordica charantia): a review of efficacy and safety.
12561513;2001 Jul;na;blood sugar AND Momordica charantia;[Effects of cactus, alove veral, momorcica charantia on reducing the blood glucose of diabetic mice].
12499084;2003 Jan;na;blood sugar AND Momordica charantia;Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats.
12458487;2002 Dec;na;blood sugar AND Momordica charantia;Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts.
12164268;2002 May;na;blood sugar AND Momordica charantia;The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism.
11814149;2001 Oct;na;blood sugar AND Momordica charantia;Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice.
11518024;2001 Aug;na;blood sugar AND Momordica charantia;Antihyperglycaemic effect of Diamed, a herbal formulation, in experimental diabetes in rats.
11448544;2001 Aug;na;blood sugar AND Momordica charantia;Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice.
11390126;2001 Jul;na;blood sugar AND Momordica charantia;Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats.
11113993;2000 Dec;na;blood sugar AND Momordica charantia;Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia.
10967491;2000 Sep;na;blood sugar AND Momordica charantia;Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.
10758656;1999 Apr;na;blood sugar AND Momordica charantia;Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients.
10711628;2000;na;blood sugar AND Momordica charantia;Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract.
22556818;1997 Jul;na;blood sugar AND Momordica charantia;Hypoglycaemic action of momordica charantia in normal and diabetic mice.
23194773;1996 Mar;na;blood sugar AND Momordica charantia;Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae).
8817639;1996 Jan;na;blood sugar AND Momordica charantia;Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes.
7477242;1995;na;blood sugar AND Momordica charantia;Effect of dietary intake of freeze dried bitter gourd (Momordica charantia) in streptozotocin induced diabetic rats.
7853862;1994 Oct;na;blood sugar AND Momordica charantia;Hypoglycaemic effect of Momordica charantia extracts in normoglycaemic or cyproheptadine-induced hyperglycaemic mice.
8255932;1993 Oct;na;blood sugar AND Momordica charantia;Studies on hypoglycemic effects of fruit pulp, seed, and whole plant of Momordica charantia on normal and diabetic model rats.
8389127;1993 May 15;na;blood sugar AND Momordica charantia;Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase.
8510714;1993;na;blood sugar AND Momordica charantia;Influence of bitter gourd (Momordica charantia) on growth and blood constituents in albino rats.
1464400;1992 Nov;na;blood sugar AND Momordica charantia;[Hypoglycemic effects of Siamese Momordica charantia and Phyllanthus urinaria extracts in streptozotocin-induced diabetic rats (the 1st report)].
1797856;1991 Oct 4;na;blood sugar AND Momordica charantia;Method for detecting the lectin activity of Momordica charantia transferred from micro two-dimensional electrophoretic gel on to nitrocellulose.
2077547;1990 Oct;na;blood sugar AND Momordica charantia;Hypoglycaemic effect of Momordica charantia extracts.
2620957;1989 Aug;na;blood sugar AND Momordica charantia;Blood sugar lowering potentiality of selected Cucurbitaceae plants of Indian origin.
2777367;1989 Apr-Jun;na;blood sugar AND Momordica charantia;Effects of long term feeding of acetone extract of Momordica charantia (whole fruit powder) on alloxan diabetic albino rats.
3387455;1988 Mar;na;blood sugar AND Momordica charantia;Effect of Momordica charantia Linn. pomous aqueous extract on cataractogenesis in murrin alloxan diabetics.
3821134;1986 Oct;na;blood sugar AND Momordica charantia;Effects of alpha-momorcharin, beta-momorcharin and alpha-trichosanthin on lipogenesis and testicular and adrenal steroidogenesis in vitro and plasma-glucose levels in vivo.
3807390;1986 Sep;na;blood sugar AND Momordica charantia;Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.
3851122;1985 Jun;na;blood sugar AND Momordica charantia;Influence of balsam pear (the fruit of Momordica charantia L.) on blood sugar level.
3899464;1985 Mar;na;blood sugar AND Momordica charantia;Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice.
6492834;1984 Jul;na;blood sugar AND Momordica charantia;Oral hypoglycaemic activity of some medicinal plants of Sri Lanka.
6806502;1982 Apr;na;blood sugar AND Momordica charantia;Trial of Momordica charantia Linn (Karela) powder in patients with maturity-onset diabetes.
6811427;1982 Mar;na;blood sugar AND Momordica charantia;Effects of bittergourd (Momordica charantia) seed & glibenclamide in streptozotocin induced diabetes mellitus.
7280086;1981 Jul;na;blood sugar AND Momordica charantia;Effect of Momordica charantia on blood glucose level of normal and alloxan-diabetic rabbits.
6786635;1981 Jun 6;na;blood sugar AND Momordica charantia;Improvement in glucose tolerance due to Momordica charantia (karela).
20078273;1977;na;blood sugar AND Momordica charantia;Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source.
29892950;2018 Jun;na;digestion AND Momordica charantia;Obese rats supplemented with bitter melon display marked shifts in the expression of genes controlling inflammatory response and lipid metabolism by RNA-Seq analysis of colonic mucosa.
29655677;2018 Mar 15;na;digestion AND Momordica charantia;An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
28994284;2017 Oct 25;na;digestion AND Momordica charantia;Gastro-Resistant Insulin Receptor-Binding Peptide from Momordica charantia Improved the Glucose Tolerance in Streptozotocin-Induced Diabetic Mice via Insulin Receptor Signaling Pathway.
26988505;2016 Aug 1;na;digestion AND Momordica charantia;Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein.
26221047;2015 Oct;na;digestion AND Momordica charantia;Detection of RNA nucleoside modifications with the uridine-specific ribonuclease MC1 from Momordica charantia.
24116036;2013;na;digestion AND Momordica charantia;Novel inhibitor cystine knot peptides from Momordica charantia.
10471373;1999 Sep 7;na;digestion AND Momordica charantia;Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active.
7763984;1993 Jul;na;digestion AND Momordica charantia;The complete amino acid sequence of momordin-a, a ribosome-inactivating protein from the seeds of bitter gourd (Momordica charantia).
1328793;1992;na;digestion AND Momordica charantia;Deoxyribonucleolytic activity of alpha- and beta-momorcharins.
1368729;1991 Aug;na;digestion AND Momordica charantia;Primary structures of N-linked oligosaccharides of momordin-a, a ribosome-inactivating protein from Momordica charantia seeds.
2060635;1991 Jun 24;na;digestion AND Momordica charantia;The complete amino acid sequence of ribonuclease from the seeds of bitter gourd (Momordica charantia).
28729836;2017;na;nutrient absorption AND Momordica charantia;An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes.
31005847;2019 Mar 23;na;metabolism AND Momordica charantia;Momordica charantia (bitter melon) modulates adipose tissue inflammasome gene expression and adipose-gut inflammatory cross talk in high-fat diet (HFD)-fed mice.
30902279;2019 Aug 1;na;metabolism AND Momordica charantia;Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.
30797330;2019 Jul 1;na;metabolism AND Momordica charantia;Influence of different pasteurization techniques on antidiabetic, antioxidant and sensory quality of debittered bitter gourd juice during storage.
30790347;2019 Feb 20;na;metabolism AND Momordica charantia;Possible molecular mechanisms of glucose-lowering activities of Momordica charantia (karela) in diabetes.
30729394;2019 Feb 7;na;metabolism AND Momordica charantia;Magneto-Priming Improved Nutraceutical Potential and Antimicrobial Activity of Momordica charantia L. Without Affecting Nutritive Value.
30660678;2019 Mar;na;metabolism AND Momordica charantia;Redox and thylakoid membrane proteomic analysis reveals the Momordica (Momordica charantia L.) rootstock-induced photoprotection of cucumber leaves under short-term heat stress.
30628614;2019 Jan 22;na;metabolism AND Momordica charantia;Polysaccharides from fermented Momordica charantia ameliorate obesity in high-fat induced obese rats.
30600821;2019 Jan 22;na;metabolism AND Momordica charantia;Dietary wild bitter gourd displays selective androgen receptor modulator like activity and improves the muscle decline of orchidectomized mice.
30551527;2019 Jan;na;metabolism AND Momordica charantia;Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
30536964;2019 Apr;na;metabolism AND Momordica charantia;Study of pancreatic lipase inhibition kinetics and LC-QTOF-MS-based identification of bioactive constituents of Momordica charantia fruits.
30532795;2018;na;metabolism AND Momordica charantia;Effect of Bitter Melon Extracts on Lipid Levels in Japanese Subjects: A Randomized Controlled Study.
30400958;2018 Nov 6;na;metabolism AND Momordica charantia;Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation.
30391593;2019 Feb 1;na;metabolism AND Momordica charantia;Preparation of a Momordica charantia L. polysaccharidechromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes.
30360709;2019;na;metabolism AND Momordica charantia;Molecular Concept of Diabetic Wound Healing: Effective Role of Herbal Remedies.
30318521;2018 Nov 14;na;metabolism AND Momordica charantia;Momordica charantia extracts protect against inhibition of endothelial angiogenesis by advanced glycation endproducts in vitro.
30317922;2019 Feb;na;metabolism AND Momordica charantia;Identification of triterpene biosynthetic genes from Momordica charantia using RNA-seq analysis.
30249986;2018 Sep 24;na;metabolism AND Momordica charantia;Momordica charantia Ethanol Extract Attenuates H(2)O(2)-Induced Cell Death by Its Antioxidant and Anti-Apoptotic Properties in Human Neuroblastoma SK-N-MC Cells.
30241862;2018 Dec 1;na;metabolism AND Momordica charantia;Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats.
30208938;2018 Sep 12;na;metabolism AND Momordica charantia;Potential adverse effects of botanical supplementation in high-fat-fed female mice.
30180967;2018 Oct 30;na;metabolism AND Momordica charantia;Transcriptomic analysis of Momordica charantia polysaccharide on streptozotocin-induced diabetic rats.
30074275;2018 Nov;na;metabolism AND Momordica charantia;Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth.
29892950;2018 Jun;na;metabolism AND Momordica charantia;Obese rats supplemented with bitter melon display marked shifts in the expression of genes controlling inflammatory response and lipid metabolism by RNA-Seq analysis of colonic mucosa.
29884151;2018 Jun 8;na;metabolism AND Momordica charantia;Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka.
29776414;2018 May 18;na;metabolism AND Momordica charantia;GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.
29753870;2018 Sep;na;metabolism AND Momordica charantia;Bitter gourd (Momordica charantia) as a rich source of bioactive components to combat cancer naturally: Are we on the right track to fully unlock its potential as inhibitor of deregulated signaling pathways.
29655703;2018 Mar 15;na;metabolism AND Momordica charantia;The effects of wild bitter gourd fruit extracts on ICAM-1 expression in pulmonary epithelial cells of C57BL/6J mice and microRNA-221/222 knockout mice: Involvement of the miR-221/-222/PI3K/AKT/NF-kappaB pathway.
29655690;2018 Mar 15;na;metabolism AND Momordica charantia;BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages.
29655677;2018 Mar 15;na;metabolism AND Momordica charantia;An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
29595191;2018 May;na;metabolism AND Momordica charantia;Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery.
29574244;2018 Apr;na;metabolism AND Momordica charantia;Alpha-momorcharin enhances Tobacco mosaic virus resistance in tobacco(NN) by manipulating jasmonic acid-salicylic acid crosstalk.
29533122;2018 Apr 3;na;metabolism AND Momordica charantia;Self-discrimination in vine tendrils of different plant families.
29466305;2018 Feb 21;na;metabolism AND Momordica charantia;Identification and Characterization of Phenylpropanoid Biosynthetic Genes and Their Accumulation in Bitter Melon (Momordica charantia).
29463104;2018;na;metabolism AND Momordica charantia;Momordica charantia Inhibits Inflammatory Responses in Murine Macrophages via Suppression of TAK1.
29431598;2018 Jul;na;metabolism AND Momordica charantia;Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus.
29405623;2018 Apr;na;metabolism AND Momordica charantia;Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice.
29339109;2018 Apr 24;na;metabolism AND Momordica charantia;Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania.
29307809;2018 May;na;metabolism AND Momordica charantia;Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition.
29287196;2018 Feb;na;metabolism AND Momordica charantia;The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis.
29164155;2017;na;metabolism AND Momordica charantia;New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis.
29113110;2017 Nov 6;na;metabolism AND Momordica charantia;Two Paralogous Genes Encoding Auxin Efflux Carrier Differentially Expressed in Bitter Gourd (Momordica charantia).
29110587;2017 Dec;na;metabolism AND Momordica charantia;Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats.
29077199;2018 May;na;metabolism AND Momordica charantia;Accumulation and distribution characteristics of biomass and nitrogen in bitter gourd (Momordica charantia L.) under different fertilization strategies.
28994284;2017 Oct 25;na;metabolism AND Momordica charantia;Gastro-Resistant Insulin Receptor-Binding Peptide from Momordica charantia Improved the Glucose Tolerance in Streptozotocin-Induced Diabetic Mice via Insulin Receptor Signaling Pathway.
28962621;2017 Sep 29;na;metabolism AND Momordica charantia;The anti-adiposity effect of bitter melon seed oil is solely attributed to its fatty acid components.
28856793;2017 Nov;na;metabolism AND Momordica charantia;Identification of a Triterpenoid as a Novel PPARgamma Activator Derived from Formosan Plants.
28834733;2017 Nov 15;na;metabolism AND Momordica charantia;Development of a phosphorylated Momordica charantia protein system for inhibiting susceptible dose-dependent C. albicans to available antimycotics: An allosteric regulation of protein.
28737900;2017 Aug 23;na;metabolism AND Momordica charantia;Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
28730971;2018;na;metabolism AND Momordica charantia;Apoptosis and Anti-cancer Drug Discovery: The Power of Medicinal Fungi and Plants.
28651578;2017 Jun 26;na;metabolism AND Momordica charantia;Characterization of phytoconstituents and evaluation of antimicrobial activity of silver-extract nanoparticles synthesized from Momordica charantia fruit extract.
28623919;2017 Jun 17;na;metabolism AND Momordica charantia;Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study.
28621938;2017 Jul 28;na;metabolism AND Momordica charantia;Inhibition of Proliferation of Vascular Smooth Muscle Cells by Cucurbitanes from Momordica charantia.
28474032;2017 May 24;na;metabolism AND Momordica charantia;Momordica charantia: a popular health-promoting vegetable with multifunctionality.
28465362;2017 Jun;na;metabolism AND Momordica charantia;Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.
28458274;2017 Jun 29;na;metabolism AND Momordica charantia;Supplementation with Hualian No. 4 wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) extract increases anti-fatigue activities and enhances exercise performance in mice.
28335529;2017 Mar 20;na;metabolism AND Momordica charantia;Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium.
28120728;2017;na;metabolism AND Momordica charantia;Momordicacharantia: A New Strategic Vision to Improve the Therapy of Endoplasmic Reticulum Stress.
28118725;2017 Apr;na;metabolism AND Momordica charantia;Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
28109806;2017 Apr;na;metabolism AND Momordica charantia;Momordica charantia polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the NF-kappaB signaling pathway.
28092345;2017 Jan 16;na;metabolism AND Momordica charantia;Acute effects of a beverage containing bitter melon extract (CARELA) on postprandial glycemia among prediabetic adults.
28090686;2017 Nov;na;metabolism AND Momordica charantia;Effectively enhancing cytotoxic and apoptotic effects of alpha-momorcharin by integrating a heparin-binding peptide.
28064559;2017 Dec;na;metabolism AND Momordica charantia;Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.
28049460;2017 Jan 3;na;metabolism AND Momordica charantia;Bitter melon protects against ER stress in LS174T colonic epithelial cells.
28028039;2017 Feb 1;na;metabolism AND Momordica charantia;Draft genome sequence of bitter gourd (Momordica charantia), a vegetable and medicinal plant in tropical and subtropical regions.
27973445;2016 Dec 12;na;metabolism AND Momordica charantia;Roles of Peroxisome Proliferator-Activated Receptor alpha in Bitter Melon Seed Oil-Corrected Lipid Disorders and Conversion of alpha-Eleostearic Acid into Rumenic Acid in C57BL/6J Mice.
27878888;2017 Feb;na;metabolism AND Momordica charantia;Metabolomics Reveals that Momordica charantia Attenuates Metabolic Changes in Experimental Obesity.
27809255;2016 Oct 31;na;metabolism AND Momordica charantia;Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity.
27748816;2016 Nov;na;metabolism AND Momordica charantia;Antidiabetic activities of a cucurbitanetype triterpenoid compound from Momordica charantia in alloxaninduced diabetic mice.
27774692;2017 Feb;na;metabolism AND Momordica charantia;Isolation and partial characterization of 3 nontoxic d-galactose-specific isolectins from seeds of Momordica balsamina.
27751827;2016 Dec 24;na;metabolism AND Momordica charantia;Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats.
27739168;2016 Nov;na;metabolism AND Momordica charantia;The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
27731813;2016 Sep;na;metabolism AND Momordica charantia;Dietary supplementation of bitter gourd reduces the risk of hypercholesterolemia in cholesterol fed sprague dawley rats.
27731809;2016 Sep;na;metabolism AND Momordica charantia;Hypoglycemic and hypolipidemic effects of Lactobacillus fermentum, fruit extracts of Syzygium cumini and Momordica charantia on diabetes induced mice.
27628414;2016 Sep 15;na;metabolism AND Momordica charantia;BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells.
27538854;2016 Dec;na;metabolism AND Momordica charantia;(1)H NMR-based metabolic study reveals the improvements of bitter melon (Momordica charantia) on energy metabolism in diet-induced obese mouse.
27513747;2016;na;metabolism AND Momordica charantia;Antiglycation and Antioxidant Properties of Momordica charantia.
27498497;2016 Jul;na;metabolism AND Momordica charantia;Variation in antioxidant enzyme activities, growth and some physiological parameters of bitter melon (Momordica charantia) under salinity and chromium stress.
27452666;2016 Oct;na;metabolism AND Momordica charantia;Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
27418544;2016 Nov;na;metabolism AND Momordica charantia;Influence of pomegranate seed oil and bitter melon aqueous extract on polyunsaturated fatty acids and their lipoxygenase metabolites concentration in serum of rats.
27352776;2016 Sep;na;metabolism AND Momordica charantia;Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats.
27335129;2016 Sep;na;metabolism AND Momordica charantia;Methanol Extract of Bitter Melon Alleviates UVB-Induced MMPs Expression via MAP Kinase and AP-1 Signaling in Human Dermal Fibroblasts in vitro.
27262837;2016 May 16;na;metabolism AND Momordica charantia;Cytotoxicity mechanism of alpha-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activation.
27260465;2016 Jul;na;metabolism AND Momordica charantia;A conjugated fatty acid present at high levels in bitter melon seed favorably affects lipid metabolism in hepatocytes by increasing NAD(+)/NADH ratio and activating PPARalpha, AMPK and SIRT1 signaling pathway.
27238589;2016 Oct;na;metabolism AND Momordica charantia;Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats.
27120805;2016 May 31;na;metabolism AND Momordica charantia;Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
27035419;2016 Jun;na;metabolism AND Momordica charantia;MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells.
27020281;2016 Aug;na;metabolism AND Momordica charantia;Structural and functional characterization of recombinant napin-like protein of Momordica charantia expressed in methylotrophic yeast Pichia pastoris.
26988505;2016 Aug 1;na;metabolism AND Momordica charantia;Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein.
26926586;2016 Mar 1;na;metabolism AND Momordica charantia;A triterpenoid from wild bitter gourd inhibits breast cancer cells.
26691274;2016 Mar 30;na;metabolism AND Momordica charantia;Flexible CDOCKER: Development and application of a pseudo-explicit structure-based docking method within CHARMM.
26653879;2016;na;metabolism AND Momordica charantia;Hypocholesterolaemic mechanism of bitter melon aqueous extracts via inhibition of pancreatic cholesterol esterase and reduction of cholesterol micellar solubility.
26648038;2015 Dec;na;metabolism AND Momordica charantia;Structural studies on a non-toxic homologue of type II RIPs from bitter gourd: Molecular basis of non-toxicity, conformational selection and glycan structure.
26537230;2016 Jan;na;metabolism AND Momordica charantia;Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture.
26487740;2016 Sep;na;metabolism AND Momordica charantia;Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
26425278;2015 Oct;na;metabolism AND Momordica charantia;The effects of Momordica charantia on obesity and lipid profiles of mice fed a high-fat diet.
26418816;2015;na;metabolism AND Momordica charantia;Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics.
26323301;2015 Sep;na;metabolism AND Momordica charantia;Cleavage of nicotinamide adenine dinucleotide by the ribosome-inactivating protein from Momordica charantia.
26318666;2015 Nov;na;metabolism AND Momordica charantia;Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice.
26221047;2015 Oct;na;metabolism AND Momordica charantia;Detection of RNA nucleoside modifications with the uridine-specific ribonuclease MC1 from Momordica charantia.
26158641;2015 Aug 24;na;metabolism AND Momordica charantia;Detection of Binding Site Molecular Interaction Field Similarities.
26142512;2015 Jul;na;metabolism AND Momordica charantia;Comparative study of antioxidant, metal chelating and antiglycation activities of Momordica charantia flesh and pulp fractions.
26088353;2015;na;metabolism AND Momordica charantia;Tetracyclic triterpenoids in herbal medicines and their activities in diabetes and its complications.
26071815;2015 Jul;na;metabolism AND Momordica charantia;The cytotoxicology of momordicins I and II on Spodoptera litura cultured cell line SL-1.
26047102;2015;na;metabolism AND Momordica charantia;De Novo Assembly of Bitter Gourd Transcriptomes: Gene Expression and Sequence Variations in Gynoecious and Monoecious Lines.
25884170;2015 Apr 11;na;metabolism AND Momordica charantia;Supplementation of fresh ucche (Momordica charantia L. var. muricata Willd) prevented oxidative stress, fibrosis and hepatic damage in CCl4 treated rats.
25797209;2015 Jul;na;metabolism AND Momordica charantia;Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity.
25778708;2015 Apr 21;na;metabolism AND Momordica charantia;Design, synthesis and biological evaluation of novel peptide MC2 analogues from Momordica charantia as potential anti-diabetic agents.
25771428;2015 May;na;metabolism AND Momordica charantia;Biosynthesis of silver nanoparticles using Momordica charantia leaf broth: Evaluation of their innate antimicrobial and catalytic activities.
25760384;2015 Mar;na;metabolism AND Momordica charantia;The antigluconeogenic activity of cucurbitacins from Momordica charantia.
25730809;2015 Mar;na;metabolism AND Momordica charantia;A plausible mechanism of biosorption in dual symbioses by vesicular-arbuscular mycorrhizal in plants.
25681721;2015 Apr 10;na;metabolism AND Momordica charantia;Zirconium phosphatidylcholine-based nanocapsules as an in vivo degradable drug delivery system of MAP30, a momordica anti-HIV protein.
25672620;2015 Apr;na;metabolism AND Momordica charantia;Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells.
25639923;2016 Jan-Feb;na;metabolism AND Momordica charantia;Constitutive expression of McCHIT1-PAT enhances resistance to rice blast and herbicide, but does not affect grain yield in transgenic glutinous rice.
25623883;2015 Jan 26;na;metabolism AND Momordica charantia;Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.
25573293;2015 May;na;metabolism AND Momordica charantia;Alpha-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
25520930;2014;na;metabolism AND Momordica charantia;Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis.
25517785;2016 Jun;na;metabolism AND Momordica charantia;Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells.
25510970;2015 Apr;na;metabolism AND Momordica charantia;Momordica charantia polysaccharides could protect against cerebral ischemia/reperfusion injury through inhibiting oxidative stress mediated c-Jun N-terminal kinase 3 signaling pathway.
25488547;2015 Mar;na;metabolism AND Momordica charantia;Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-kappaB and JNK pathways in high-fat-fed OLETF rats.
25469855;2015 Jan;na;metabolism AND Momordica charantia;5beta,19-epoxycucurbitane triterpenoids from Momordica charantia and their anti-inflammatory and cytotoxic activity.
25464078;2015 Jan 12;na;metabolism AND Momordica charantia;Pectic polysaccharide from the green fruits of Momordica charantia (Karela): structural characterization and study of immunoenhancing and antioxidant properties.
25425149;2015 Jan;na;metabolism AND Momordica charantia;13-Oxo-9(Z),11(E),15(Z)-octadecatrienoic acid activates peroxisome proliferator-activated receptor gamma in adipocytes.
25380206;2014 Nov 6;na;metabolism AND Momordica charantia;[Conjugated linolenic acids (CLnA, super CLA)--natural sources and biological activity].
25371774;2014;na;metabolism AND Momordica charantia;Protective effect of Momordica charantia fruit extract on hyperglycaemia-induced cardiac fibrosis.
25350230;2014 Nov;na;metabolism AND Momordica charantia;Characteristics and functionality enhancement by glycosylation of bitter melon (Momordica charantia) seed protein.
25264226;2015;na;metabolism AND Momordica charantia;Protection of Momordica charantia polysaccharide against intracerebral hemorrhage-induced brain injury through JNK3 signaling pathway.
25256475;2014 Nov 26;na;metabolism AND Momordica charantia;Syntheses of new rare earth complexes with carboxymethylated polysaccharides and evaluation of their in vitro antifungal activities.
25253099;2015 Jan;na;metabolism AND Momordica charantia;The effect of Momordica charantia intake on the estrogen receptors ESRalpha/ESRbeta gene levels and apoptosis on uterine tissue in ovariectomy rats.
25203338;2014;na;metabolism AND Momordica charantia;Involvement of liver in diabetes mellitus: herbal remedies.
25203006;2014;na;metabolism AND Momordica charantia;Characterization of a soluble phosphatidic acid phosphatase in bitter melon (Momordica charantia).
25200916;2015 Feb;na;metabolism AND Momordica charantia;Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma.
25192240;2015 Mar;na;metabolism AND Momordica charantia;Momordica charantia seed extract exhibits strong anticoagulant effect by specifically interfering in intrinsic pathway of blood coagulation and dissolves fibrin clot.
25178064;2014 Aug 29;na;metabolism AND Momordica charantia;Immunomodulatory activity and partial characterisation of polysaccharides from Momordica charantia.
25153878;2014 Aug 21;na;metabolism AND Momordica charantia;Anti-inflammatory effect of Momordica charantia in sepsis mice.
25144709;2014 Sep 10;na;metabolism AND Momordica charantia;A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway.
25139598;2014 Aug;na;metabolism AND Momordica charantia;Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-beta expression.
25116119;2014 Jul;na;metabolism AND Momordica charantia;Transport in Caco-2 cell monolayers of antidiabetic cucurbitane triterpenoids from Momordica charantia fruits.
24836069;2014 Jun 23;na;metabolism AND Momordica charantia;New compounds from acid hydrolyzed products of the fruits of Momordica charantia L. and their inhibitory activity against protein tyrosine phosphatas 1B.
24786488;2016;na;metabolism AND Momordica charantia;PEGylation alleviates the non-specific toxicities of Alpha-Momorcharin and preserves its antitumor efficacy in vivo.
24751968;2014 Jul;na;metabolism AND Momordica charantia;Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
24722532;2014;na;metabolism AND Momordica charantia;Fusion of protegrin-1 and plectasin to MAP30 shows significant inhibition activity against dengue virus replication.
24672797;2014;na;metabolism AND Momordica charantia;Effects of Momordica charantia L. on the blood rheological properties in diabetic patients.
24664243;2014 May;na;metabolism AND Momordica charantia;Wild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses.
24637239;2014 Jun 1;na;metabolism AND Momordica charantia;Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia.
24523491;2014 Apr;na;metabolism AND Momordica charantia;Bitter gourd inhibits the development of obesity-associated fatty liver in C57BL/6 mice fed a high-fat diet.
24467890;2014 Mar;na;metabolism AND Momordica charantia;Enhanced resistance to blast fungus in rice (Oryza sativa L.) by expressing the ribosome-inactivating protein alpha-momorcharin.
24372263;2013;na;metabolism AND Momordica charantia;An important role of carotenoids in protection of photosynthetic apparatus under VAM inoculation on Momordica charantia.
24360831;2014 Jan 15;na;metabolism AND Momordica charantia;Honokiol trimers and dimers via biotransformation catalyzed by Momordica charantia peroxidase: novel and potent alpha-glucosidase inhibitors.
24358329;2013;na;metabolism AND Momordica charantia;Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues.
24302224;2014 Jul;na;metabolism AND Momordica charantia;Greenhouse-grown bitter melon: production and quality characteristics.
24297707;2014 Mar;na;metabolism AND Momordica charantia;Effect of alpha, beta momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines.
24295371;2014 Jan;na;metabolism AND Momordica charantia;Momordica charantia and type 2 diabetes: from in vitro to human studies.
24262540;2014 Apr 1;na;metabolism AND Momordica charantia;Proteomic analysis of heat treated bitter gourd (Momordica charantia L. var. Hong Kong Green) using 2D-DIGE.
24189525;2013 Nov 5;na;metabolism AND Momordica charantia;Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice.
24116036;2013;na;metabolism AND Momordica charantia;Novel inhibitor cystine knot peptides from Momordica charantia.
23827133;2013 Jul;na;metabolism AND Momordica charantia;The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver.
23777339;2013 Nov;na;metabolism AND Momordica charantia;Alpha-momorcharin: a ribosome-inactivating protein from Momordica charantia, possessing DNA cleavage properties.
23765337;2014 Mar;na;metabolism AND Momordica charantia;Catalytic synthesis and antioxidant activity of sulfated polysaccharide from Momordica charantia L.
23692809;2014 Feb;na;metabolism AND Momordica charantia;Antinociceptive and antiallodynic effects of Momordica charantia L. in tibial and sural nerve transection-induced neuropathic pain in rats.
23638033;2013;na;metabolism AND Momordica charantia;Activation of AMPK by bitter melon triterpenoids involves CaMKKbeta.
23622112;2013 Apr 26;na;metabolism AND Momordica charantia;Nanobiotechnology can boost crop production and quality: first evidence from increased plant biomass, fruit yield and phytomedicine content in bitter melon (Momordica charantia).
23610006;2014 Mar;na;metabolism AND Momordica charantia;Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice.
23431975;2013;na;metabolism AND Momordica charantia;Increased virulence of transgenic Trichoderma koningi strains to the Asian corn borer larvae by overexpressing heterologous chit42 gene with chitin-binding domains.
23414136;2013 Mar 13;na;metabolism AND Momordica charantia;Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor.
23360233;2013 Feb 20;na;metabolism AND Momordica charantia;alpha-Glucosidase inhibitors via green pathway: biotransformation for bicoumarins catalyzed by Momordica charantia peroxidase.
23320026;2012;na;metabolism AND Momordica charantia;Comprehensive Evaluation of Anti-hyperglycemic Activity of Fractionated Momordica charantia Seed Extract in Alloxan-Induced Diabetic Rats.
23229317;2013 Feb;na;metabolism AND Momordica charantia;Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection.
23203059;2012 Nov 2;na;metabolism AND Momordica charantia;Effect of superfine grinding on antidiabetic activity of bitter melon powder.
23153065;2012 Dec 5;na;metabolism AND Momordica charantia;Riboflavin accumulation and characterization of cDNAs encoding lumazine synthase and riboflavin synthase in bitter melon (Momordica charantia).
23053765;2013 Jun;na;metabolism AND Momordica charantia;In vitro toxicity and antidiabetic activity of a newly developed polyherbal formulation (MAC-ST/001) in streptozotocin-induced diabetic Wistar rats.
23043987;2013 Jan 1;na;metabolism AND Momordica charantia;Molecular cloning and characterization of cDNAs encoding carotenoid cleavage dioxygenase in bitter melon (Momordica charantia).
23020844;2012 Sep 29;na;metabolism AND Momordica charantia;Antioxidant, antiglycation and cytotoxicity evaluation of selected medicinal plants of the Mascarene Islands.
22983699;2013 Jan;na;metabolism AND Momordica charantia;Alpha-momorcharin, a RIP produced by bitter melon, enhances defense response in tobacco plants against diverse plant viruses and shows antifungal activity in vitro.
22957888;2012 Dec;na;metabolism AND Momordica charantia;Kuguaglycoside C, a constituent of Momordica charantia, induces caspase-independent cell death of neuroblastoma cells.
22802682;2012;na;metabolism AND Momordica charantia;Preparation of an antitumor and antivirus agent: chemical modification of alpha-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
22782871;2012 Jul;na;metabolism AND Momordica charantia;Glycosidic inhibitors of melanogenesis from leaves of Momordica charantia.
22654584;2012;na;metabolism AND Momordica charantia;Traditional medicinal herbs and food plants have the potential to inhibit key carbohydrate hydrolyzing enzymes in vitro and reduce postprandial blood glucose peaks in vivo.
22623391;2012 Jul;na;metabolism AND Momordica charantia;Bitter melon seed oil-attenuated body fat accumulation in diet-induced obese mice is associated with cAMP-dependent protein kinase activation and cell death in white adipose tissue.
22579806;2012 Nov 1;na;metabolism AND Momordica charantia;The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo.
22575975;2012 Jun;na;metabolism AND Momordica charantia;In vitro modulation of oxidative burst via release of reactive oxygen species from immune cells by extracts of selected tropical medicinal herbs and food plants.
22554586;2012 Aug;na;metabolism AND Momordica charantia;In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
22523346;2012 May;na;metabolism AND Momordica charantia;Isolation and characterization of 10 SSR markers of Momordica charantia (Cucurbitaceae).
22493531;2012;na;metabolism AND Momordica charantia;Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon).
22465903;2012 Jul;na;metabolism AND Momordica charantia;cis-9, trans-11, trans-13-Conjugated linolenic acid induces apoptosis and sustained ERK phosphorylation in 3T3-L1 preadipocytes.
22457205;2012 May;na;metabolism AND Momordica charantia;Mechanisms underlying decreased hepatic triacylglycerol and cholesterol by dietary bitter melon extract in the rat.
22451660;2012 May 11;na;metabolism AND Momordica charantia;Conjugated fatty acid synthesis: residues 111 and 115 influence product partitioning of Momordica charantia conjugase.
22344919;2012 Feb;na;metabolism AND Momordica charantia;Cucurbitane triterpenoids from the leaves of Momordica charantia, and their cancer chemopreventive effects and cytotoxicities.
22329631;2012 Apr 1;na;metabolism AND Momordica charantia;A review of the hypoglycemic effects of five commonly used herbal food supplements.
22295710;2011 Dec;na;metabolism AND Momordica charantia;[Preparation and identification of monoclonal antibody against alpha-momorcharins].
22266361;2012 Mar;na;metabolism AND Momordica charantia;Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
22262229;2012 Nov;na;metabolism AND Momordica charantia;Molecular cloning and functional analysis of a recombinant ribosome-inactivating protein (alpha-momorcharin) from Momordica charantia.
22248180;2012 Apr;na;metabolism AND Momordica charantia;Inhibition of nuclear transcription factor-kappaB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia.
22235885;2012 Feb;na;metabolism AND Momordica charantia;Trypanocide, cytotoxic, and antifungal activities of Momordica charantia.
22191631;2012 Feb;na;metabolism AND Momordica charantia;Antidiabetic potentials of Momordica charantia: multiple mechanisms behind the effects.
22191569;2012 Apr;na;metabolism AND Momordica charantia;Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-alpha serine/threonine-protein kinase signaling.
22182422;2012 Sep 28;na;metabolism AND Momordica charantia;Antioxidant and anti-inflammatory effect of conjugated linolenic acid isomers against streptozotocin-induced diabetes.
22172326;2012 Jan 31;na;metabolism AND Momordica charantia;Alpha-momorcharin possessing high immunogenicity, immunotoxicity and hepatotoxicity in SD rats.
22134530;2012 Apr;na;metabolism AND Momordica charantia;RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways.
22133295;2011 Dec 15;na;metabolism AND Momordica charantia;Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.
22125958;2011 Nov-Dec;na;metabolism AND Momordica charantia;Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits.
22125906;2011;na;metabolism AND Momordica charantia;Catalyzed degradation of disperse dyes by calcium alginate-pectin entrapped bitter gourd (Momordica charantia) peroxidase.
22120616;2012 Aug;na;metabolism AND Momordica charantia;Balsamin, a novel ribosome-inactivating protein from the seeds of Balsam apple Momordica balsamina.
22101446;2012 Feb;na;metabolism AND Momordica charantia;Tandem multimer expression and preparation of hypoglycemic peptide MC6 from Momordica charantia in Escherichia coli.
22001161;2012 Jan;na;metabolism AND Momordica charantia;Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11beta-hydroxysteroid dehydrogenase type 1 inhibitor.
21933914;2012 Jan;na;metabolism AND Momordica charantia;Momordica Charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo.
21930012;2011 Oct;na;metabolism AND Momordica charantia;Niacin-bound chromium increases life span in Zucker Fatty Rats.
21913530;2010 Oct-Dec;na;metabolism AND Momordica charantia;Effect of methanolic seed extract of Momordica charantia on body weight and serum cholesterol level of male Sprague-Dawley rats.
21911444;2011 Dec;na;metabolism AND Momordica charantia;Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
21875286;2011;na;metabolism AND Momordica charantia;Anticlastogenic and anticarcinogenic potential of Thai bitter gourd fruits.
21839642;2011 Sep 1;na;metabolism AND Momordica charantia;Dimerization of piceatannol by Momordica charantia peroxidase and alpha-glucosidase inhibitory activity of the biotransformation products.
21814874;2012 Jun;na;metabolism AND Momordica charantia;Comparative study of hypocholesterolemic and hypolipidemic effects of conjugated linolenic acid isomers against induced biochemical perturbations and aberration in erythrocyte membrane fluidity.
21813810;2011 Sep;na;metabolism AND Momordica charantia;Supplementation of bitter melon to rats fed a high-fructose diet during gestation and lactation ameliorates fructose-induced dyslipidemia and hepatic oxidative stress in male offspring.
21791551;2011 Oct;na;metabolism AND Momordica charantia;Dietary kakrol (Momordica dioica Roxb.) flesh inhibits triacylglycerol absorption and lowers the risk for development of fatty liver in rats.
21639917;2011 Jun 3;na;metabolism AND Momordica charantia;Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation.
21626510;2011 Oct;na;metabolism AND Momordica charantia;Gene cloning and expression of a novel hypoglycaemic peptide from Momordica charantia.
21568930;2011 Jul;na;metabolism AND Momordica charantia;Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties.
21473271;2011 Jan;na;metabolism AND Momordica charantia;Removal of benzidine from polluted water by soluble and immobilized peroxidase in batch processes and continuous horizontal bed reactor.
21456596;2011 May 11;na;metabolism AND Momordica charantia;Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia.
21429659;2011 Jul 28;na;metabolism AND Momordica charantia;Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf.
21414769;2012 Jan;na;metabolism AND Momordica charantia;Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance.
21392566;2011 Apr 26;na;metabolism AND Momordica charantia;Wild bitter gourd extract up-regulates mRNA expression of PPARalpha, PPARgamma and their target genes in C57BL/6J mice.
21332398;2011 Mar;na;metabolism AND Momordica charantia;Momordica charantia seed extract reduces pre-adipocyte viability, affects lactate dehydrogenase release, and lipid accumulation in 3T3-L1 cells.
21293936;2011 Jul;na;metabolism AND Momordica charantia;Inhibition of proliferation by agricultural plant extracts in seven human adult T-cell leukaemia (ATL)-related cell lines.
21277185;2011 Nov;na;metabolism AND Momordica charantia;Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice.
21211558;2011 Mar 24;na;metabolism AND Momordica charantia;Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
21174950;2010 Aug;na;metabolism AND Momordica charantia;Anti-hyperglycemic and anti-oxidative effect of aqueous extract of Momordica charantia pulp and Trigonella foenum graecum seed in alloxan-induced diabetic rats.
21139270;2010 Dec;na;metabolism AND Momordica charantia;Cucurbitane triterpenoids from Momordica charantia and their cytoprotective activity in tert-butyl hydroperoxide-induced hepatotoxicity of HepG2 cells.
21128828;2011 Jan-Feb;na;metabolism AND Momordica charantia;Dietary bitter melon seed increases peroxisome proliferator-activated receptor-gamma gene expression in adipose tissue, down-regulates the nuclear factor-kappaB expression, and alleviates the symptoms associated with metabolic syndrome.
21117023;2011 Jan;na;metabolism AND Momordica charantia;Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats.
21080948;2010 Nov 16;na;metabolism AND Momordica charantia;Mining the bitter melon (momordica charantia l.) seed transcriptome by 454 analysis of non-normalized and normalized cDNA populations for conjugated fatty acid metabolism-related genes.
21056650;2011 Jan 27;na;metabolism AND Momordica charantia;Neuroprotective effect of Momordica charantia in global cerebral ischemia and reperfusion induced neuronal damage in diabetic mice.
20837082;2010 Dec;na;metabolism AND Momordica charantia;Application of fly ash adsorbed peroxidase for the removal of bisphenol A in batch process and continuous reactor: assessment of genotoxicity of its product.
20731662;2010 Oct;na;metabolism AND Momordica charantia;Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo.
20717728;2010 Sep;na;metabolism AND Momordica charantia;Screening of dried plant seed extracts for adiponectin production activity and tumor necrosis factor-alpha inhibitory activity on 3T3-L1 adipocytes.
20716916;2009 Nov-Dec;na;metabolism AND Momordica charantia;The plant extracts of Momordica charantia and Trigonella foenum-graecum have anti-oxidant and anti-hyperglycemic properties for cardiac tissue during diabetes mellitus.
20622451;2010;na;metabolism AND Momordica charantia;The quenching-resolved fluorescence spectrum and its application to studies of the folding/unfolding of trypsin inhibitor from seeds of the bitter gourd.
20615270;2010 Dec;na;metabolism AND Momordica charantia;Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice.
20587058;2010 Jun 29;na;metabolism AND Momordica charantia;Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes.
20544988;2010 May;na;metabolism AND Momordica charantia;[Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity].
20521979;2010 Jun;na;metabolism AND Momordica charantia;Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db/db mice.
20521977;2010 Jun;na;metabolism AND Momordica charantia;Momordica charantia maintains normal glucose levels and lipid profiles and prevents oxidative stress in diabetic rats subjected to chronic sucrose load.
20460803;2010 May;na;metabolism AND Momordica charantia;alpha-Glucosidase inhibition properties of cucurbitane-type triterpene glycosides from the fruits of Momordica charantia.
20450027;2010 Jan-Mar;na;metabolism AND Momordica charantia;Effect of aqueous leaf extract of Momordica charantia on intestinal enzyme activities in diarrhoeagenic mice.
20427259;2010 May 9;na;metabolism AND Momordica charantia;[Role of phytotherapy in the prevention and treatment of obesity].
20379957;2010 Oct;na;metabolism AND Momordica charantia;Cucurbitane-type triterpenoids from Momordica charantia.
20347917;2010 Jun;na;metabolism AND Momordica charantia;Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells.
20198408;2010 Jun;na;metabolism AND Momordica charantia;Bitter melon: antagonist to cancer.
20183996;2009 Dec 14;na;metabolism AND Momordica charantia;Phenol-mediated decolorization and removal of disperse dyes by bitter gourd (Momordica charantia) peroxidase.
20179194;2010 Mar 1;na;metabolism AND Momordica charantia;Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
20132905;2010 Jun;na;metabolism AND Momordica charantia;Momordicatin purified from fruits of Momordica charantia is effective to act as a potent antileishmania agent.
20032574;2009;na;metabolism AND Momordica charantia;Activating effect of momordin, extract of bitter melon (Momordica Charantia L.), on the promoter of human PPARdelta.
19839003;2009 Jan;na;metabolism AND Momordica charantia;Bitter melon protects against lipid peroxidation caused by immobilization stress in albino rats.
19789297;2009 Oct;na;metabolism AND Momordica charantia;Eleostearic Acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism.
19761040;2009 Jul;na;metabolism AND Momordica charantia;Antihyperglycemic, antihyperlipidemic and antioxidant effects of Dihar, a polyherbal ayurvedic formulation in streptozotocin induced diabetic rats.
19744549;2009 Dec 10;na;metabolism AND Momordica charantia;Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPAR gamma and PI3K.
19727528;2009 Sep;na;metabolism AND Momordica charantia;Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol.
19697337;2009 Aug;na;metabolism AND Momordica charantia;Biocatalytic production of acyclic bis[bibenzyls] from dihydroresveratrol by crude Momordica charantia peroxidase.
19665538;2009 Oct 29;na;metabolism AND Momordica charantia;No effect of acute, single dose oral administration of Momordica charantia Linn., on glycemia, energy expenditure and appetite: a pilot study in non-diabetic overweight men.
19538123;2009 May;na;metabolism AND Momordica charantia;Enzymatic properties of a recombinant phospholipid hydroperoxide glutathione peroxidase from Momordica charantia and its complementation function in yeast.
19509199;2009 Jun;na;metabolism AND Momordica charantia;Complementary and alternative medicine for the treatment of type 2 diabetes.
19508570;2009 Oct;na;metabolism AND Momordica charantia;The effect of topical extract of Momordica charantia (bitter gourd) on wound healing in nondiabetic rats and in rats with diabetes induced by streptozotocin.
19501279;2009 Jun 25;na;metabolism AND Momordica charantia;Antiulcer activity of methanolic extract of Momordica charantia L. in rats.
19429344;2009 May 4;na;metabolism AND Momordica charantia;Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
19384952;2009 Aug 15;na;metabolism AND Momordica charantia;Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.
19362455;2009 May;na;metabolism AND Momordica charantia;Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
19330915;2009 Mar 18;na;metabolism AND Momordica charantia;Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages.
19223201;2009 Apr;na;metabolism AND Momordica charantia;Induction of hepatocyte growth factor production in human dermal fibroblasts and their proliferation by the extract of bitter melon pulp.
19216552;2009 Mar 11;na;metabolism AND Momordica charantia;Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk-soymilk supplemented with Momordica charantia.
19090290;2007 Nov 15;na;metabolism AND Momordica charantia;In vitro plant regeneration from direct and indirect organogenesis of Memordica charantia.
19015823;2009 Sep;na;metabolism AND Momordica charantia;Application of calcium alginate-starch entrapped bitter gourd (Momordica charantia) peroxidase for the removal of colored compounds from a textile effluent in batch as well as in continuous reactor.
19014972;2008 Dec 22;na;metabolism AND Momordica charantia;Characterization of lectin isolated from Momordica charantia seed as a B cell activator.
19014889;2009 Jan 9;na;metabolism AND Momordica charantia;Fluorescence studies on the interaction of hydrophobic ligands with Momordica charantia (bitter gourd) seed lectin.
18983991;2009 Feb 12;na;metabolism AND Momordica charantia;Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats.
18977074;2009 May 30;na;metabolism AND Momordica charantia;Decolorization of textile effluent by bitter gourd peroxidase immobilized on concanavalin A layered calcium alginate-starch beads.
18945457;2008 Nov;na;metabolism AND Momordica charantia;Identification of an amino acid determinant of pH regiospecificity in a seed lipoxygenase from Momordica charantia.
18855210;2008;na;metabolism AND Momordica charantia;Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems.
18831340;2008 Jan;na;metabolism AND Momordica charantia;Effects of alcoholic extract of Momordica charantia (Linn.) whole fruit powder on the pancreatic islets of alloxan diabetic albino rats.
18822337;2008 Dec;na;metabolism AND Momordica charantia;Interactions between cytochromes P450, glutathione S-transferases and Ghanaian medicinal plants.
18809315;2009 Jan;na;metabolism AND Momordica charantia;Biosorptive removal of arsenic from drinking water.
18800899;2008 Sep;na;metabolism AND Momordica charantia;Effect of Indian herbal hypoglycemic agents on antioxidant capacity and trace elements content in diabetic rats.
18751697;2008 Dec;na;metabolism AND Momordica charantia;Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus.
18656931;2008 Aug 27;na;metabolism AND Momordica charantia;A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase.
18603588;2008 Oct;na;metabolism AND Momordica charantia;The unfolding of alpha-momorcharin proceeds through the compact folded intermediate.
18550200;2008 Aug;na;metabolism AND Momordica charantia;Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet.
18540100;2008 Jun;na;metabolism AND Momordica charantia;Heterogeneous packing in the folding/unfolding intermediate state of bitter gourd trypsin inhibitor.
18537696;2008 Jun;na;metabolism AND Momordica charantia;Traditional chinese medicine in treatment of metabolic syndrome.
18537692;2008 Jun;na;metabolism AND Momordica charantia;Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans.
18525182;2008 May;na;metabolism AND Momordica charantia;Immunoadjuvant activity of crude lectin extracted from Momordica charantia seed.
18489106;2008 Jun 11;na;metabolism AND Momordica charantia;Bitter gourd suppresses lipopolysaccharide-induced inflammatory responses.
18473951;2008;na;metabolism AND Momordica charantia;Purification and characterization of a novel peroxidase from bitter gourd (Momordica charantia).
18413160;2009 Jan-Feb;na;metabolism AND Momordica charantia;Effect of bitter gourd and spent turmeric on glycoconjugate metabolism in streptozotocin-induced diabetic rats.
18355726;2008 Mar;na;metabolism AND Momordica charantia;Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway.
18321395;2008 Oct;na;metabolism AND Momordica charantia;Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions.
18246454;2008 May;na;metabolism AND Momordica charantia;Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells.
18202535;2007 Dec;na;metabolism AND Momordica charantia;Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.
18068320;2008 Feb 12;na;metabolism AND Momordica charantia;Antiprotozoal and cytotoxic screening of 45 plant extracts from Democratic Republic of Congo.
18024034;2008 Jan 17;na;metabolism AND Momordica charantia;Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
17942003;2008 Apr;na;metabolism AND Momordica charantia;Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats.
17892543;2007 Sep 24;na;metabolism AND Momordica charantia;An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract.
17696480;2007 Sep 19;na;metabolism AND Momordica charantia;Oligomers of resveratrol and ferulic acid prepared by peroxidase-catalyzed oxidation and their protective effects on cardiac injury.
17693694;2006;na;metabolism AND Momordica charantia;Antioxidative effect of conjugated linolenic acid in diabetic and non-diabetic blood: an in vitro study.
17651527;2008 Feb;na;metabolism AND Momordica charantia;Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats.
17579811;2007 Oct;na;metabolism AND Momordica charantia;Expression of a ribosome-inactivating protein gene in bitter melon is induced by Sphaerotheca fuliginea and abiotic stimuli.
17566887;2007 Jun;na;metabolism AND Momordica charantia;Antioxidant activity of commonly consumed plant foods of India: contribution of their phenolic content.
17493509;2007 Jun;na;metabolism AND Momordica charantia;The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
17485855;2007 May;na;metabolism AND Momordica charantia;Cloning and characterization of a balsam pear class I chitinase gene (Mcchit1) and its ectopic expression enhances fungal resistance in transgenic plants.
17392113;2007;na;metabolism AND Momordica charantia;The reparative effects of Momordica Charantia Linn. extract on HIT-T15 pancreatic beta-cells.
17363205;2007 May 30;na;metabolism AND Momordica charantia;Water extracts from Momordica charantia increase glucose uptake and adiponectin secretion in 3T3-L1 adipose cells.
17341830;2007 Mar;na;metabolism AND Momordica charantia;Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction.
17320168;2007 Jun 1;na;metabolism AND Momordica charantia;A role of glycosyl moieties in the stabilization of bitter gourd (Momordica charantia) peroxidase.
17263505;2007 Feb 7;na;metabolism AND Momordica charantia;Biotransformation of sinapic acid catalyzed by Momordica charantia peroxidase.
17137839;2007 Jun;na;metabolism AND Momordica charantia;Polyclonal antibodies mediated immobilization of a peroxidase from ammonium sulphate fractionated bitter gourd (Momordica charantia) proteins.
17092672;2007 Mar 21;na;metabolism AND Momordica charantia;Effect of exogenous ATP on Momordica charantia Linn. (Cucurbitaceae) induced inhibition of D-glucose, L-tyrosine and fluid transport across rat everted intestinal sacs in vitro.
16940700;2006 Jun;na;metabolism AND Momordica charantia;Potassium excretion in healthy Japanese women was increased by a dietary intervention utilizing home-parcel delivery of Okinawan vegetables.
16910221;2006 Jul;na;metabolism AND Momordica charantia;Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
16847441;2006 Aug;na;metabolism AND Momordica charantia;Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.
16815658;2006 Nov 24;na;metabolism AND Momordica charantia;Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats.
16764905;2006 Nov;na;metabolism AND Momordica charantia;Potential applications of immobilized bitter gourd (Momordica charantia) peroxidase in the removal of phenols from polluted water.
16762380;2006 Jun;na;metabolism AND Momordica charantia;Conjugated fatty acids accumulate to high levels in phospholipids of metabolically engineered soybean and Arabidopsis seeds.
16755004;2006 Jun;na;metabolism AND Momordica charantia;Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
16675313;2006 May;na;metabolism AND Momordica charantia;In vitro refolded napin-like protein of Momordica charantia expressed in Escherichia coli displays properties of native napin.
16532259;2006 Jun;na;metabolism AND Momordica charantia;Effect of bitter gourd and spent turmeric on constituents of glycosaminoglycans in different tissues in streptozotocin induced diabetic rats.
16298503;2006 Apr 21;na;metabolism AND Momordica charantia;Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats.
16261524;2005 Oct;na;metabolism AND Momordica charantia;Antioxidant activity of five vegetables traditionally consumed by South-Asian migrants in Bradford, Yorkshire, UK.
16252877;2005 Jul;na;metabolism AND Momordica charantia;[Relationships of Aulacophora beetles feeding behavior with cucurbitacin types in host crops].
16251604;2005 Nov;na;metabolism AND Momordica charantia;Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression.
16196458;2005;na;metabolism AND Momordica charantia;Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet.
16187012;2005 Sep;na;metabolism AND Momordica charantia;Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.
16162395;2005 Dec 1;na;metabolism AND Momordica charantia;Inhibitory effect of some selected nutraceutic herbs on LDL glycation induced by glucose and glyoxal.
16111053;2005 May;na;metabolism AND Momordica charantia;[The hypoglycemic effects of crude polysaccharides extract from Momordica charantia in mice].
16106394;2005 May;na;metabolism AND Momordica charantia;Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus.
16051087;2005 Nov;na;metabolism AND Momordica charantia;Partially purified bitter gourd (Momordica charantia) peroxidase catalyzed decolorization of textile and other industrially important dyes.
16009633;2005 May;na;metabolism AND Momordica charantia;Occurrence of yellow mosaic geminiviral disease on bitter gourd (Momordica charantia) and its impact on phytochemical contents.
16007724;2005 Aug;na;metabolism AND Momordica charantia;Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats.
15997142;2005 Jul;na;metabolism AND Momordica charantia;Biotransformation of ferulic acid into two new dihydrotrimers by Momordica charantia peroxidase.
15975176;2005 May;na;metabolism AND Momordica charantia;Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines.
15961301;2005 Aug;na;metabolism AND Momordica charantia;Bitter gourd seed fatty acid rich in 9c,11t,13t-conjugated linolenic acid induces apoptosis and up-regulates the GADD45, p53 and PPARgamma in human colon cancer Caco-2 cells.
15930730;2005 Jun;na;metabolism AND Momordica charantia;Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats.
15927932;2005;na;metabolism AND Momordica charantia;Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats.
15924947;2005 Jul;na;metabolism AND Momordica charantia;Potential of immobilized bitter gourd (Momordica charantia) peroxidases in the decolorization and removal of textile dyes from polluted wastewater and dyeing effluent.
15918591;2005 May;na;metabolism AND Momordica charantia;Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats.
15820223;2005 May 1;na;metabolism AND Momordica charantia;Energetics of carbohydrate binding to Momordica charantia (bitter gourd) lectin: an isothermal titration calorimetric study.
15795421;2005 Apr;na;metabolism AND Momordica charantia;Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells.
15724444;2005 Jan;na;metabolism AND Momordica charantia;Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats.
15693713;2005 Jan;na;metabolism AND Momordica charantia;Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants.
15660964;2005 Feb;na;metabolism AND Momordica charantia;Experimental evidence for in vitro fluid transport in the presence of a traditional medicinal fruit extract across rat everted intestinal sacs.
15630201;2004;na;metabolism AND Momordica charantia;Oxidative stress is the master operator of drug and chemically-induced programmed and unprogrammed cell death: Implications of natural antioxidants in vivo.
15597317;2004 Nov;na;metabolism AND Momordica charantia;Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats.
15527066;2004 Aug;na;metabolism AND Momordica charantia;The effects of bitter melon (Momordica charantia) extracts on serum and liver lipid parameters in hamsters fed cholesterol-free and cholesterol-enriched diets.
15521566;2004 Apr;na;metabolism AND Momordica charantia;Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM).
15383230;2004 Fall;na;metabolism AND Momordica charantia;The evaluation of nitric oxide scavenging activity of certain Indian medicinal plants in vitro: a preliminary study.
15362491;2004 Jun;na;metabolism AND Momordica charantia;Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes.
15362486;2004 Jun;na;metabolism AND Momordica charantia;Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat.
15351776;2004 Oct;na;metabolism AND Momordica charantia;Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells.
15322360;2004 Aug;na;metabolism AND Momordica charantia;Amino acids conserved at the C-terminal half of the ribonuclease T2 family contribute to protein stability of the enzymes.
15265047;2004 Aug;na;metabolism AND Momordica charantia;Thermodynamic analysis of porphyrin binding to Momordica charantia (bitter gourd) lectin.
15248030;2004 Dec;na;metabolism AND Momordica charantia;Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
15236800;2004;na;metabolism AND Momordica charantia;Does bitter melon contain an activator of AMP-activated kinase?
15234774;2004 Aug;na;metabolism AND Momordica charantia;Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity.
15233304;2004 Mar;na;metabolism AND Momordica charantia;Cancer preventive potential of Momordica charantia L. against benzo(a)pyrene induced fore-stomach tumourigenesis in murine model system.
15120448;2004 Apr;na;metabolism AND Momordica charantia;The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats.
14974734;2003 Dec;na;metabolism AND Momordica charantia;Bitter melon malt vinegar increases daily energy turnover in rats.
14758046;2004 Feb;na;metabolism AND Momordica charantia;Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice.
14758036;2004 Feb;na;metabolism AND Momordica charantia;Momordica charantia extracts inhibit uptake of monosaccharide and amino acid across rat everted gut sacs in-vitro.
14730127;2003 Dec;na;metabolism AND Momordica charantia;Induction of anti-inflammatory responses by dietary Momordica charantia L. (bitter gourd).
14729399;2004 Feb 6;na;metabolism AND Momordica charantia;Tissue specific expression and immunohistochemical localization of glutathione S-transferase in streptozotocin induced diabetic rats: modulation by Momordica charantia (karela) extract.
14723327;2003 Jul;na;metabolism AND Momordica charantia;Evaluation of the efficacy of bitter gourd (momordica charantia) as an oral hypoglycemic agent--a randomized controlled clinical trial.
14631118;2003 Nov-Dec;na;metabolism AND Momordica charantia;Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells.
14600392;2003 Nov;na;metabolism AND Momordica charantia;Oxidation of ferulic acid by Momordica charantia peroxidase and related anti-inflammation activity changes.
12902059;2003 Sep;na;metabolism AND Momordica charantia;Antihyperglycemic effects of three extracts from Momordica charantia.
12842136;2003 Jul;na;metabolism AND Momordica charantia;Bitter gourd proteinase inhibitors: potential growth inhibitors of Helicoverpa armigera and Spodoptera litura.
12710209;2003;na;metabolism AND Momordica charantia;Preparation of DNA-protein complexes suitable for spectroscopic analysis.
12678140;2003 Jan;na;metabolism AND Momordica charantia;Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
12672924;2003 Apr;na;metabolism AND Momordica charantia;Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet.
12663610;2003 Apr;na;metabolism AND Momordica charantia;Systematic review of herbs and dietary supplements for glycemic control in diabetes.
12645269;2002;na;metabolism AND Momordica charantia;[Cloning and characterization of a homologous gene of plant class V chitinase from balsampear, Momordica charantia Linn].
12616598;2003;na;metabolism AND Momordica charantia;Natural dietary agents can protect against DMBA genotoxicity in lymphocytes as revealed by single cell gel electrophoresis assay.
12561513;2001 Jul;na;metabolism AND Momordica charantia;[Effects of cactus, alove veral, momorcica charantia on reducing the blood glucose of diabetic mice].
12432225;2002 Nov-Dec;na;metabolism AND Momordica charantia;Differential effects of foods traditionally regarded as 'heating' and 'cooling' on prostaglandin E(2) production by a macrophage cell line.
12230008;2002;na;metabolism AND Momordica charantia;Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice.
12224646;2002 Jul;na;metabolism AND Momordica charantia;Alpha-glucosidase inhibitor from the seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa.
12164268;2002 May;na;metabolism AND Momordica charantia;The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism.
11966976;2002 May;na;metabolism AND Momordica charantia;Purification and characterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica charantia) seeds.
11906182;2002 Mar 29;na;metabolism AND Momordica charantia;Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII.
11814149;2001 Oct;na;metabolism AND Momordica charantia;Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice.
11747298;2001 Dec 15;na;metabolism AND Momordica charantia;Dietary effects of bitter gourd oil on blood and liver lipids of rats.
11686924;2001 Nov;na;metabolism AND Momordica charantia;Contribution of Gln9 and Phe80 to substrate binding in ribonuclease MC1 from bitter gourd seeds.
11573962;2001 Oct 5;na;metabolism AND Momordica charantia;Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
11518024;2001 Aug;na;metabolism AND Momordica charantia;Antihyperglycaemic effect of Diamed, a herbal formulation, in experimental diabetes in rats.
11458453;2001 Jun;na;metabolism AND Momordica charantia;HIV inhibitor from Thai bitter gourd.
11448544;2001 Aug;na;metabolism AND Momordica charantia;Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice.
11390126;2001 Jul;na;metabolism AND Momordica charantia;Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats.
11286022;2001 Feb;na;metabolism AND Momordica charantia;Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
11269887;2001 Mar;na;metabolism AND Momordica charantia;Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats.
11268104;2001 Mar;na;metabolism AND Momordica charantia;Stimulation of protein biosynthesis in rat hepatocytes by extracts of Momordica charantia.
11148047;2001 Jan 16;na;metabolism AND Momordica charantia;Amino acid residues in ribonuclease MC1 from bitter gourd seeds which are essential for uridine specificity.
11113993;2000 Dec;na;metabolism AND Momordica charantia;Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia.
11025141;2000 Nov;na;metabolism AND Momordica charantia;Role of bittergourd fruit juice in stz-induced diabetic state in vivo and in vitro.
11004551;2000 Jul 14;na;metabolism AND Momordica charantia;Effect of P(2)' site tryptophan and P(20)' site deletion of Momordica charantia trypsin inhibitor II on inhibition of proteinases.
10967491;2000 Sep;na;metabolism AND Momordica charantia;Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.
10964705;2000 Aug 28;na;metabolism AND Momordica charantia;Crystal structures of the ribonuclease MC1 from bitter gourd seeds, complexed with 2'-UMP or 3'-UMP, reveal structural basis for uridine specificity.
10958332;2000 Aug;na;metabolism AND Momordica charantia;Prevention of carcinogen-induced mouse skin papilloma by whole fruit aqueous extract of Momordica charantia.
10803962;2000 Mar;na;metabolism AND Momordica charantia;Expression and mutational analysis of amino acid residues involved in catalytic activity in a ribonuclease MC1 from the seeds of bitter gourd.
10767416;2000 Apr 14;na;metabolism AND Momordica charantia;The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase.
10758656;1999 Apr;na;metabolism AND Momordica charantia;Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients.
10736572;2000 May;na;metabolism AND Momordica charantia;Intrinsic ribonuclease activities in ribonuclease and ribosome-inactivating proteins from the seeds of bitter gourd.
10711628;2000;na;metabolism AND Momordica charantia;Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract.
10625418;2000 Jan;na;metabolism AND Momordica charantia;The food of sweet and bitter fancy.
10571185;1999 Nov 12;na;metabolism AND Momordica charantia;Solution structure of anti-HIV-1 and anti-tumor protein MAP30: structural insights into its multiple functions.
10536026;1999 Oct 26;na;metabolism AND Momordica charantia;Biosynthetic origin of conjugated double bonds: production of fatty acid components of high-value drying oils in transgenic soybean embryos.
10530800;1999;na;metabolism AND Momordica charantia;Preparation of highly purified momordin II without ribonuclease activity.
10524768;1999 Jul;na;metabolism AND Momordica charantia;Crystal structure of the complex formed between bovine beta-trypsin and MCTI-A, a trypsin inhibitor of squash family, at 1.8-A resolution.
10452099;1999 Mar;na;metabolism AND Momordica charantia;Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
10446375;1999 Aug 17;na;metabolism AND Momordica charantia;Crystal structure of a ribonuclease from the seeds of bitter gourd (Momordica charantia) at 1.75 A resolution.
10102236;1999 Feb;na;metabolism AND Momordica charantia;Dietary effects of conjugated octadecatrienoic fatty acid (9 cis, 11 trans, 13 trans) levels on blood lipids and nonenzymatic in vitro lipid peroxidation in rats.
9875234;1998 Dec 9;na;metabolism AND Momordica charantia;Ribosome inactivating protein and lectin from bitter melon (Momordica charantia) seeds: sequence comparison with related proteins.
9812020;1998;na;metabolism AND Momordica charantia;Nutritional characteristics of oil containing conjugated octadecatrienoic fatty acid.
9743580;1998 Sep;na;metabolism AND Momordica charantia;Histochemical localization of glycoconjugates on microglial cells in Alzheimer's disease brain samples by using Abrus precatorius, Maackia amurensis, Momordica charantia, and Sambucus nigra lectins.
9687077;1998 May;na;metabolism AND Momordica charantia;Antispermatogenic and androgenic activities of Momordica charantia (Karela) in albino rats.
9674955;1998 Jun;na;metabolism AND Momordica charantia;Effects of neem flowers, Thai and Chinese bitter gourd fruits and sweet basil leaves on hepatic monooxygenases and glutathione S-transferase activities, and in vitro metabolic activation of chemical carcinogens in rats.
9648227;1998 May;na;metabolism AND Momordica charantia;Chemical modifications of momordin-a and luffin-a, ribosome-inactivating proteins from the seeds of Momordica charantia and Luffa cylindrica: involvement of His140, Tyr165, and Lys231 in the protein-synthesis inhibitory activity.
9544697;1998 Jan 16;na;metabolism AND Momordica charantia;Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papillomagenesis.
9464500;1998 Jan 9;na;metabolism AND Momordica charantia;Postnatal efficacy of Momordica charantia peel, pulp, seed and whole fruit extract in the detoxication pathway of suckling neonates and lactating mice.
12223677;1997 Apr;na;metabolism AND Momordica charantia;In Vivo Studies of the Biosynthesis of [alpha]-Eleostearic Acid in the Seed of Momordica charantia L.
9188186;1997 Apr;na;metabolism AND Momordica charantia;Plant foods in the management of diabetes mellitus: vegetables as potential hypoglycaemic agents.
8980648;1996 Dec 5;na;metabolism AND Momordica charantia;Purification and sequencing of napin-like protein small and large chains from Momordica charantia and Ricinus communis seeds and determination of sites phosphorylated by plant Ca(2+)-dependent protein kinase.
8954120;1996 Dec 4;na;metabolism AND Momordica charantia;Characterization of the enzymatic mechanism of gamma-momorcharin, a novel ribosome-inactivating protein with lower molecular weight of 11,500 purified from the seeds of bitter gourd (Momordica charantia).
8937480;1996 Nov 22;na;metabolism AND Momordica charantia;Effect of bitter melon (Momordica charantia) fruit juice on the hepatic cytochrome P450-dependent monooxygenases and glutathione S-transferases in streptozotocin-induced diabetic rats.
8799450;1996 May;na;metabolism AND Momordica charantia;Purification in high yield and characterisation of the galactose-specific lectin from the seeds of snake gourd (Trichosanthes anguina).
8950282;1996;na;metabolism AND Momordica charantia;Demonstration of ribonuclease activity in the plant ribosome-inactivating proteins alpha- and beta-momorcharins.
8817639;1996 Jan;na;metabolism AND Momordica charantia;Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes.
8795701;1996;na;metabolism AND Momordica charantia;A highly efficient procedure for purifying the ribosome-inactivating proteins alpha- and beta-momorcharins from Momordica charantia seeds, N-terminal sequence comparison and establishment of their N-glycosidase activity.
7568024;1995 Sep 12;na;metabolism AND Momordica charantia;Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
7766185;1995 Mar;na;metabolism AND Momordica charantia;Isolation and amino acid sequences of two trypsin inhibitors from the seeds of bitter gourd (Momordica charantia).
7608135;1995 Feb;na;metabolism AND Momordica charantia;Trypsin and elastase inhibitors from bitter gourd (Momordica charantia LINN.) seeds: purification, amino acid sequences, and inhibitory activities of four new inhibitors.
7477242;1995;na;metabolism AND Momordica charantia;Effect of dietary intake of freeze dried bitter gourd (Momordica charantia) in streptozotocin induced diabetic rats.
7853870;1994 Oct;na;metabolism AND Momordica charantia;Effect of Momordica charantia on key hepatic enzymes.
7853862;1994 Oct;na;metabolism AND Momordica charantia;Hypoglycaemic effect of Momordica charantia extracts in normoglycaemic or cyproheptadine-induced hyperglycaemic mice.
7967659;1994 Jul 8;na;metabolism AND Momordica charantia;Effect of trichosanthin and momorcharins on isolated rat hepatocytes.
8075985;1994 Jan 15;na;metabolism AND Momordica charantia;The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin.
8026716;1994 Jan;na;metabolism AND Momordica charantia;Action of alpha-momorcharin, a ribosome inactivating protein, on cultured tumor cell lines.
8389127;1993 May 15;na;metabolism AND Momordica charantia;Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase.
7682894;1993 May;na;metabolism AND Momordica charantia;In vitro and in vivo properties of an anti-CD5-momordin immunotoxin on normal and neoplastic T lymphocytes.
8510714;1993;na;metabolism AND Momordica charantia;Influence of bitter gourd (Momordica charantia) on growth and blood constituents in albino rats.
1474592;1992 Dec 20;na;metabolism AND Momordica charantia;Crystallization and preliminary X-ray diffraction analysis of a plant ribonuclease from the seeds of the bitter gourd Momordica charantia.
1464400;1992 Nov;na;metabolism AND Momordica charantia;[Hypoglycemic effects of Siamese Momordica charantia and Phyllanthus urinaria extracts in streptozotocin-induced diabetic rats (the 1st report)].
1383043;1992 Jul;na;metabolism AND Momordica charantia;beta-Momorcharin, a plant glycoprotein, inhibits synthesis of macromolecules in embryos, splenocytes and tumor cells.
1551419;1992 Feb 3;na;metabolism AND Momordica charantia;Amino acid sequencing of a trypsin inhibitor by refined 1.6 A X-ray crystal structure of its complex with porcine beta-trypsin.
1797856;1991 Oct 4;na;metabolism AND Momordica charantia;Method for detecting the lectin activity of Momordica charantia transferred from micro two-dimensional electrophoretic gel on to nitrocellulose.
1679433;1991 Sep 5;na;metabolism AND Momordica charantia;Purification and amino acid sequence of a bitter gourd inhibitor against an acidic amino acid-specific endopeptidase of Streptomyces griseus.
1894001;1991 Sep 2;na;metabolism AND Momordica charantia;The complete amino acid sequence of ribonuclease from the seeds of bitter gourd (Momordica charantia).
1938101;1991 Jul;na;metabolism AND Momordica charantia;Isolation of a ribosome-inactivating and abortifacient protein from seeds of Luffa acutangula.
2060635;1991 Jun 24;na;metabolism AND Momordica charantia;The complete amino acid sequence of ribonuclease from the seeds of bitter gourd (Momordica charantia).
1841996;1991;na;metabolism AND Momordica charantia;Screening of the antimalarial activity of plants of the Cucurbitaceae family.
1699801;1990 Oct 15;na;metabolism AND Momordica charantia;MAP 30: a new inhibitor of HIV-1 infection and replication.
2077547;1990 Oct;na;metabolism AND Momordica charantia;Hypoglycaemic effect of Momordica charantia extracts.
2255210;1990 Sep;na;metabolism AND Momordica charantia;Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats.
2388259;1990 Aug 5;na;metabolism AND Momordica charantia;Crystals of alpha-momorcharin. A new ribosome-inactivating protein.
2175958;1990;na;metabolism AND Momordica charantia;Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines.
2104468;1990;na;metabolism AND Momordica charantia;[Studies on the active constituents of Momordica charantia L].
2777367;1989 Apr-Jun;na;metabolism AND Momordica charantia;Effects of long term feeding of acetone extract of Momordica charantia (whole fruit powder) on alloxan diabetic albino rats.
2545472;1989;na;metabolism AND Momordica charantia;Effects of lectins with various carbohydrate binding specificities on lipid metabolism in isolated rat and hamster adipocytes.
3372132;1988 Mar;na;metabolism AND Momordica charantia;Trichosanthin, alpha-momorcharin and beta-momorcharin: identity of abortifacient and ribosome-inactivating proteins.
2898450;1988 Mar-Apr;na;metabolism AND Momordica charantia;Effects of momorcharins on ovarian response to gonadotropin-induced superovulation in mice.
2826928;1987 Sep-Oct;na;metabolism AND Momordica charantia;Effects of ginsenosides, lectins and Momordica charantia insulin-like peptide on corticosterone production by isolated rat adrenal cells.
3318384;1987;na;metabolism AND Momordica charantia;Acid-ethanol extractable compounds from fruits and seeds of the bitter gourd Momordica charantia: effects on lipid metabolism in isolated rat adipocytes.
3106137;1987;na;metabolism AND Momordica charantia;Peptides with antilipolytic and lipogenic activities from seeds of the bitter gourd Momordica charantia (family Cucurbitaceae).
3821134;1986 Oct;na;metabolism AND Momordica charantia;Effects of alpha-momorcharin, beta-momorcharin and alpha-trichosanthin on lipogenesis and testicular and adrenal steroidogenesis in vitro and plasma-glucose levels in vivo.
3807390;1986 Sep;na;metabolism AND Momordica charantia;Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.
3807387;1986 Sep;na;metabolism AND Momordica charantia;Extra-pancreatic effects of Momordica charantia in rats.
3533814;1986 Aug;na;metabolism AND Momordica charantia;Isolation and characterization of a galactose binding lectin with insulinomimetic activities. From the seeds of the bitter gourd Momordica charantia (Family Cucurbitaceae).
3021185;1986 Aug;na;metabolism AND Momordica charantia;A steryl glycoside fraction from Momordica charantia seeds with an inhibitory action on lipid metabolism in vitro.
3520153;1986 Jan;na;metabolism AND Momordica charantia;Insulin-like molecules in Momordica charantia seeds.
4058034;1985 Jul;na;metabolism AND Momordica charantia;Screening of Trichosanthes kirilowii, Momordica charantia and Cucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity.
3899464;1985 Mar;na;metabolism AND Momordica charantia;Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice.
17340390;1985 Feb;na;metabolism AND Momordica charantia;An in vitro Study on the Effect of Momordica charantia on Glucose Uptake and Glucose Metabolism in Rats.
4011748;1985 Feb;na;metabolism AND Momordica charantia;An in vitro study on the effect of Momordica charantia on glucose uptake and glucose metabolism in rats.
6541045;1984 Jun;na;metabolism AND Momordica charantia;Cytoxicity of erythrocyte ghosts loaded with ribosome-inactivating proteins following fusion with CHO cells.
6305714;1983 Jun 27;na;metabolism AND Momordica charantia;Cytotoxicity acquired by ribosome-inactivating proteins carried by reconstituted Sendai virus envelopes.
6629594;1983;na;metabolism AND Momordica charantia;The immunomodulatory activity of the plant proteins Momordica charantia inhibitor and pokeweed antiviral protein.
6196772;1983;na;metabolism AND Momordica charantia;Purification and characterization of a cytostatic factor with anti-viral activity from the bitter melon.
6142453;1983;na;metabolism AND Momordica charantia;Purification and characterization of a cytostatic factor with anti-viral activity from the bitter melon.
17396970;1982 Nov;na;metabolism AND Momordica charantia;[Comparative study of two medicinal Cucurbitaceae].
6811427;1982 Mar;na;metabolism AND Momordica charantia;Effects of bittergourd (Momordica charantia) seed & glibenclamide in streptozotocin induced diabetes mellitus.
6765165;1982;na;metabolism AND Momordica charantia;The insulin-releasing activity of the tropical plant momordica charantia.
6284092;1982;na;metabolism AND Momordica charantia;Effect of ribosome-inactivating proteins on virus-infected cells. Inhibition of virus multiplication and of protein synthesis.
6185939;1982;na;metabolism AND Momordica charantia;Purification and characterization of a cytostatic factor from the bitter melon Momordica charantia.
6122565;1982;na;metabolism AND Momordica charantia;Guanylate cyclase activity in human leukemic and normal lymphocytes. Enzyme inhibition and cytotoxicity of plant extracts.
7280086;1981 Jul;na;metabolism AND Momordica charantia;Effect of Momordica charantia on blood glucose level of normal and alloxan-diabetic rabbits.
6786635;1981 Jun 6;na;metabolism AND Momordica charantia;Improvement in glucose tolerance due to Momordica charantia (karela).
7397226;1980 Jun 26;na;metabolism AND Momordica charantia;Studies on lectins. XLVII. Some properties of D-galactose binding lectins isolated from the seeds of Butea frondosa, Erythrina indica and Momordica charantia.
6104489;1980 May 14;na;metabolism AND Momordica charantia;Partial purification and characterization of a guanylate cyclase inhibitor with cytotoxic properties from the bitter melon (Momordica charantia).
7378061;1980 Feb 15;na;metabolism AND Momordica charantia;Inhibition of protein synthesis in vitro by proteins from the seeds of Momordica charantia (bitter pear melon).
6110273;1980;na;metabolism AND Momordica charantia;Toxicity of Momordica charantia lectin and inhibitor for human normal and leukaemic lymphocytes.
508306;1979 Aug 15;na;metabolism AND Momordica charantia;Inhibition of protein synthesis in vitro by a lectin from Momordica charantia and by other haemagglutinins.
24847;1978 Feb;na;metabolism AND Momordica charantia;Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).
725959;1978;na;metabolism AND Momordica charantia;Isolation of toxic and non-toxic lectins from the bitter pear melon Momordica charantia Linn.
20099;1977 Aug 22;na;metabolism AND Momordica charantia;Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata).
31062632;2019 May 7;na;cancer AND Momordica charantia;Alpha-momorcharin regulates cytokine expression and induces apoptosis in monocytes.
30956678;2019;na;cancer AND Momordica charantia;Momordica charantia (Indian and Chinese Bitter Melon) Extracts Inducing Apoptosis in Human Lung Cancer Cell Line A549 via ROS-Mediated Mitochodria Injury.
30647713;2018 Jun;na;cancer AND Momordica charantia;Green synthesis of zero valent colloidal nanosilver targeting A549 lung cancer cell: In vitro cytotoxicity.
30352327;2019 Jan;na;cancer AND Momordica charantia;Cucurbitane triterpenoids from the fruit of Momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities.
30249986;2018 Sep 24;na;cancer AND Momordica charantia;Momordica charantia Ethanol Extract Attenuates H(2)O(2)-Induced Cell Death by Its Antioxidant and Anti-Apoptotic Properties in Human Neuroblastoma SK-N-MC Cells.
30074275;2018 Nov;na;cancer AND Momordica charantia;Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth.
29764719;2018 Dec;na;cancer AND Momordica charantia;Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies.
29753870;2018 Sep;na;cancer AND Momordica charantia;Bitter gourd (Momordica charantia) as a rich source of bioactive components to combat cancer naturally: Are we on the right track to fully unlock its potential as inhibitor of deregulated signaling pathways.
29736383;2018 Apr;na;cancer AND Momordica charantia;Analysis of Kras gene from induced pancreatic cancer rats administered with Momordicacharantia and Ocimumbasilicum leaf extracts.
29727019;2018 Sep;na;cancer AND Momordica charantia;Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells.
29559516;2018 Apr;na;cancer AND Momordica charantia;Immunomodulatory Effects of Momordica charantia Extract in the Prevention of Oral Cancer.
29463104;2018;na;cancer AND Momordica charantia;Momordica charantia Inhibits Inflammatory Responses in Murine Macrophages via Suppression of TAK1.
29287196;2018 Feb;na;cancer AND Momordica charantia;The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis.
29061560;2018 Apr;na;cancer AND Momordica charantia;Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
28856793;2017 Nov;na;cancer AND Momordica charantia;Identification of a Triterpenoid as a Novel PPARgamma Activator Derived from Formosan Plants.
28730971;2018;na;cancer AND Momordica charantia;Apoptosis and Anti-cancer Drug Discovery: The Power of Medicinal Fungi and Plants.
28639112;2017 Oct;na;cancer AND Momordica charantia;Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells.
28474032;2017 May 24;na;cancer AND Momordica charantia;Momordica charantia: a popular health-promoting vegetable with multifunctionality.
28465362;2017 Jun;na;cancer AND Momordica charantia;Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.
28090686;2017 Nov;na;cancer AND Momordica charantia;Effectively enhancing cytotoxic and apoptotic effects of alpha-momorcharin by integrating a heparin-binding peptide.
27809255;2016 Oct 31;na;cancer AND Momordica charantia;Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity.
27748816;2016 Nov;na;cancer AND Momordica charantia;Antidiabetic activities of a cucurbitanetype triterpenoid compound from Momordica charantia in alloxaninduced diabetic mice.
27774692;2017 Feb;na;cancer AND Momordica charantia;Isolation and partial characterization of 3 nontoxic d-galactose-specific isolectins from seeds of Momordica balsamina.
27739168;2016 Nov;na;cancer AND Momordica charantia;The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
27628414;2016 Sep 15;na;cancer AND Momordica charantia;BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells.
27452666;2016 Oct;na;cancer AND Momordica charantia;Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
27391476;2016 Jul 8;na;cancer AND Momordica charantia;Cytotoxic potential of selected medicinal plants in northeast Brazil.
27262837;2016 May 16;na;cancer AND Momordica charantia;Cytotoxicity mechanism of alpha-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activation.
27120805;2016 May 31;na;cancer AND Momordica charantia;Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
27035419;2016 Jun;na;cancer AND Momordica charantia;MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells.
26968675;2016 Feb;na;cancer AND Momordica charantia;Bitter melon: a panacea for inflammation and cancer.
26926586;2016 Mar 1;na;cancer AND Momordica charantia;A triterpenoid from wild bitter gourd inhibits breast cancer cells.
26820935;2016 Apr 15;na;cancer AND Momordica charantia;Quantification of inorganic arsenic exposure and cancer risk via consumption of vegetables in southern selected districts of Pakistan.
26537230;2016 Jan;na;cancer AND Momordica charantia;Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture.
26487740;2016 Sep;na;cancer AND Momordica charantia;Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
26459126;2015 Sep;na;cancer AND Momordica charantia;[Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus III. Momordica (Momordica charantia)].
26418816;2015;na;cancer AND Momordica charantia;Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics.
25945113;2015;na;cancer AND Momordica charantia;Antibacterial and Antiproliferative Activities of Plumericin, an Iridoid Isolated from Momordica charantia Vine.
25797209;2015 Jul;na;cancer AND Momordica charantia;Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity.
25672620;2015 Apr;na;cancer AND Momordica charantia;Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells.
25573293;2015 May;na;cancer AND Momordica charantia;Alpha-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
25542240;2015 Mar;na;cancer AND Momordica charantia;Momordica charantia seed lectin: toxicity, bacterial agglutination and antitumor properties.
25517785;2016 Jun;na;cancer AND Momordica charantia;Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells.
25488547;2015 Mar;na;cancer AND Momordica charantia;Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-kappaB and JNK pathways in high-fat-fed OLETF rats.
25447153;2015 Jan;na;cancer AND Momordica charantia;Alpha-momorcharin (alpha-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivo.
25380206;2014 Nov 6;na;cancer AND Momordica charantia;[Conjugated linolenic acids (CLnA, super CLA)--natural sources and biological activity].
25264226;2015;na;cancer AND Momordica charantia;Protection of Momordica charantia polysaccharide against intracerebral hemorrhage-induced brain injury through JNK3 signaling pathway.
25200916;2015 Feb;na;cancer AND Momordica charantia;Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma.
24786488;2016;na;cancer AND Momordica charantia;PEGylation alleviates the non-specific toxicities of Alpha-Momorcharin and preserves its antitumor efficacy in vivo.
24637239;2014 Jun 1;na;cancer AND Momordica charantia;Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia.
24631764;2014 Jun;na;cancer AND Momordica charantia;Cucurbitane-type triterpenoids from the stems and leaves of Momordica charantia.
24571798;2014 Feb 26;na;cancer AND Momordica charantia;Anticancer activity of five forest crops used in African folklore: antiproliferative and pro-apoptotic effects.
24297707;2014 Mar;na;cancer AND Momordica charantia;Effect of alpha, beta momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines.
23843889;2013;na;cancer AND Momordica charantia;Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor gamma Activation.
23320038;2012;na;cancer AND Momordica charantia;Antimigratory Effects of the Methanol Extract from Momordica charantia on Human Lung Adenocarcinoma CL1 Cells.
23266484;2013 Mar;na;cancer AND Momordica charantia;Bitter melon extract inhibits proliferation of Trypanosoma brucei bloodstream forms in vitro.
23216691;2012 Dec 6;na;cancer AND Momordica charantia;Inhibitory effects of crude extracts from some edible Thai plants against replication of hepatitis B virus and human liver cancer cells.
23091557;2012;na;cancer AND Momordica charantia;Momordica charantia Extract Induces Apoptosis in Human Cancer Cells through Caspase- and Mitochondria-Dependent Pathways.
22957888;2012 Dec;na;cancer AND Momordica charantia;Kuguaglycoside C, a constituent of Momordica charantia, induces caspase-independent cell death of neuroblastoma cells.
22579806;2012 Nov 1;na;cancer AND Momordica charantia;The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo.
22554586;2012 Aug;na;cancer AND Momordica charantia;In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
22465200;2012 May 1;na;cancer AND Momordica charantia;Application of high-speed counter-current chromatography coupled with a reverse micelle solvent system to separate three proteins from Momordica charantia.
22369241;2012 Apr 18;na;cancer AND Momordica charantia;Structures of new triterpenoids and cytotoxicity activities of the isolated major compounds from the fruit of Momordica charantia L.
22344919;2012 Feb;na;cancer AND Momordica charantia;Cucurbitane triterpenoids from the leaves of Momordica charantia, and their cancer chemopreventive effects and cytotoxicities.
22266361;2012 Mar;na;cancer AND Momordica charantia;Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
22191569;2012 Apr;na;cancer AND Momordica charantia;Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-alpha serine/threonine-protein kinase signaling.
22134530;2012 Apr;na;cancer AND Momordica charantia;RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways.
21933914;2012 Jan;na;cancer AND Momordica charantia;Momordica Charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo.
21911444;2011 Dec;na;cancer AND Momordica charantia;Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
21875286;2011;na;cancer AND Momordica charantia;Anticlastogenic and anticarcinogenic potential of Thai bitter gourd fruits.
21429659;2011 Jul 28;na;cancer AND Momordica charantia;Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf.
21414769;2012 Jan;na;cancer AND Momordica charantia;Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance.
21293936;2011 Jul;na;cancer AND Momordica charantia;Inhibition of proliferation by agricultural plant extracts in seven human adult T-cell leukaemia (ATL)-related cell lines.
20939353;2010 Aug;na;cancer AND Momordica charantia;[Mineral elements analysis of Momordica charantiap seeds by ICP-AES and fatty acid profile identification of seed oil by GC-MS].
20843118;2010;na;cancer AND Momordica charantia;Chemopreventive and anticarcinogenic effects of Momordica charantia extract.
20731662;2010 Oct;na;cancer AND Momordica charantia;Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo.
20544988;2010 May;na;cancer AND Momordica charantia;[Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity].
20198408;2010 Jun;na;cancer AND Momordica charantia;Bitter melon: antagonist to cancer.
20179194;2010 Mar 1;na;cancer AND Momordica charantia;Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
20127421;2010 Apr;na;cancer AND Momordica charantia;Evaluation of native and exotic Brazilian plants for anticancer activity.
19789297;2009 Oct;na;cancer AND Momordica charantia;Eleostearic Acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism.
19747115;2009 Dec;na;cancer AND Momordica charantia;Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy.
19727528;2009 Sep;na;cancer AND Momordica charantia;Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol.
19697337;2009 Aug;na;cancer AND Momordica charantia;Biocatalytic production of acyclic bis[bibenzyls] from dihydroresveratrol by crude Momordica charantia peroxidase.
19384952;2009 Aug 15;na;cancer AND Momordica charantia;Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.
18959405;2008 Nov 26;na;cancer AND Momordica charantia;Alpha-eleostearic acid and its dihydroxy derivative are major apoptosis-inducing components of bitter gourd.
18751697;2008 Dec;na;cancer AND Momordica charantia;Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus.
18246454;2008 May;na;cancer AND Momordica charantia;Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells.
17685651;2007 Aug;na;cancer AND Momordica charantia;Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects.
17566887;2007 Jun;na;cancer AND Momordica charantia;Antioxidant activity of commonly consumed plant foods of India: contribution of their phenolic content.
17461486;2007 Mar 21;na;cancer AND Momordica charantia;Bitter gourd (Momordica charantia): a potential mechanism in anti-carcinogenesis of colon.
16847441;2006 Aug;na;cancer AND Momordica charantia;Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.
15961301;2005 Aug;na;cancer AND Momordica charantia;Bitter gourd seed fatty acid rich in 9c,11t,13t-conjugated linolenic acid induces apoptosis and up-regulates the GADD45, p53 and PPARgamma in human colon cancer Caco-2 cells.
15351776;2004 Oct;na;cancer AND Momordica charantia;Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells.
15248030;2004 Dec;na;cancer AND Momordica charantia;Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
15236800;2004;na;cancer AND Momordica charantia;Does bitter melon contain an activator of AMP-activated kinase?
15233304;2004 Mar;na;cancer AND Momordica charantia;Cancer preventive potential of Momordica charantia L. against benzo(a)pyrene induced fore-stomach tumourigenesis in murine model system.
15182917;2004 Jul;na;cancer AND Momordica charantia;Pharmacological actions and potential uses of Momordica charantia: a review.
15182427;2004 Jun;na;cancer AND Momordica charantia;Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats.
15170673;2004 Jul 20;na;cancer AND Momordica charantia;Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPARgamma expression and alteration of lipid composition.
12678140;2003 Jan;na;cancer AND Momordica charantia;Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
12616598;2003;na;cancer AND Momordica charantia;Natural dietary agents can protect against DMBA genotoxicity in lymphocytes as revealed by single cell gel electrophoresis assay.
12230008;2002;na;cancer AND Momordica charantia;Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice.
11856476;2002 Feb;na;cancer AND Momordica charantia;Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats.
11573962;2001 Oct 5;na;cancer AND Momordica charantia;Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
11286022;2001 Feb;na;cancer AND Momordica charantia;Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
10958332;2000 Aug;na;cancer AND Momordica charantia;Prevention of carcinogen-induced mouse skin papilloma by whole fruit aqueous extract of Momordica charantia.
10810336;2000 Mar-Apr;na;cancer AND Momordica charantia;Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30.
10625418;2000 Jan;na;cancer AND Momordica charantia;The food of sweet and bitter fancy.
10471373;1999 Sep 7;na;cancer AND Momordica charantia;Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active.
9674955;1998 Jun;na;cancer AND Momordica charantia;Effects of neem flowers, Thai and Chinese bitter gourd fruits and sweet basil leaves on hepatic monooxygenases and glutathione S-transferase activities, and in vitro metabolic activation of chemical carcinogens in rats.
9544697;1998 Jan 16;na;cancer AND Momordica charantia;Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papillomagenesis.
9464500;1998 Jan 9;na;cancer AND Momordica charantia;Postnatal efficacy of Momordica charantia peel, pulp, seed and whole fruit extract in the detoxication pathway of suckling neonates and lactating mice.
21559696;1994 Nov;na;cancer AND Momordica charantia;In-vitro antitumor-activity of the plant ribosome-inactivating proteins map-30 and gap-31.
8026716;1994 Jan;na;cancer AND Momordica charantia;Action of alpha-momorcharin, a ribosome inactivating protein, on cultured tumor cell lines.
7682894;1993 May;na;cancer AND Momordica charantia;In vitro and in vivo properties of an anti-CD5-momordin immunotoxin on normal and neoplastic T lymphocytes.
1474592;1992 Dec 20;na;cancer AND Momordica charantia;Crystallization and preliminary X-ray diffraction analysis of a plant ribonuclease from the seeds of the bitter gourd Momordica charantia.
1383043;1992 Jul;na;cancer AND Momordica charantia;beta-Momorcharin, a plant glycoprotein, inhibits synthesis of macromolecules in embryos, splenocytes and tumor cells.
2311123;1990 Apr 1;na;cancer AND Momordica charantia;Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia).
2175958;1990;na;cancer AND Momordica charantia;Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines.
2104468;1990;na;cancer AND Momordica charantia;[Studies on the active constituents of Momordica charantia L].
3265330;1988 Nov;na;cancer AND Momordica charantia;Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin.
6616452;1983 Nov;na;cancer AND Momordica charantia;In vivo antitumor activity of the bitter melon (Momordica charantia).
7201686;1982;na;cancer AND Momordica charantia;The cytotoxic and cytostatic effects of the bitter melon (Momordica charantia) on human lymphocytes.
6185939;1982;na;cancer AND Momordica charantia;Purification and characterization of a cytostatic factor from the bitter melon Momordica charantia.
6122565;1982;na;cancer AND Momordica charantia;Guanylate cyclase activity in human leukemic and normal lymphocytes. Enzyme inhibition and cytotoxicity of plant extracts.
6104489;1980 May 14;na;cancer AND Momordica charantia;Partial purification and characterization of a guanylate cyclase inhibitor with cytotoxic properties from the bitter melon (Momordica charantia).
6110273;1980;na;cancer AND Momordica charantia;Toxicity of Momordica charantia lectin and inhibitor for human normal and leukaemic lymphocytes.
24847;1978 Feb;na;cancer AND Momordica charantia;Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).
725959;1978;na;cancer AND Momordica charantia;Isolation of toxic and non-toxic lectins from the bitter pear melon Momordica charantia Linn.
5104841;1971 Mar;na;cancer AND Momordica charantia;The anti-growth properties of extracts from Momordica charantia L.
30628614;2019 Jan 22;na;cholesterol AND Momordica charantia;Polysaccharides from fermented Momordica charantia ameliorate obesity in high-fat induced obese rats.
30532795;2018;na;cholesterol AND Momordica charantia;Effect of Bitter Melon Extracts on Lipid Levels in Japanese Subjects: A Randomized Controlled Study.
30074275;2018 Nov;na;cholesterol AND Momordica charantia;Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth.
29655677;2018 Mar 15;na;cholesterol AND Momordica charantia;An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
29126447;2017 Nov 10;na;cholesterol AND Momordica charantia;Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia).
28623919;2017 Jun 17;na;cholesterol AND Momordica charantia;Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study.
28335529;2017 Mar 20;na;cholesterol AND Momordica charantia;Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium.
28109806;2017 Apr;na;cholesterol AND Momordica charantia;Momordica charantia polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the NF-kappaB signaling pathway.
28064559;2017 Dec;na;cholesterol AND Momordica charantia;Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.
27748816;2016 Nov;na;cholesterol AND Momordica charantia;Antidiabetic activities of a cucurbitanetype triterpenoid compound from Momordica charantia in alloxaninduced diabetic mice.
27731813;2016 Sep;na;cholesterol AND Momordica charantia;Dietary supplementation of bitter gourd reduces the risk of hypercholesterolemia in cholesterol fed sprague dawley rats.
27731809;2016 Sep;na;cholesterol AND Momordica charantia;Hypoglycemic and hypolipidemic effects of Lactobacillus fermentum, fruit extracts of Syzygium cumini and Momordica charantia on diabetes induced mice.
27190792;2016 Apr;na;cholesterol AND Momordica charantia;Evaluation of Protein Kinase Cbeta and PPARgamma Activity in Diabetic Rats Supplemented with Momordica charantia.
26653879;2016;na;cholesterol AND Momordica charantia;Hypocholesterolaemic mechanism of bitter melon aqueous extracts via inhibition of pancreatic cholesterol esterase and reduction of cholesterol micellar solubility.
26417358;2015;na;cholesterol AND Momordica charantia;Effect of Momordica charantia fruit extract on vascular complication in type 1 diabetic rats.
26045386;2014 Nov;na;cholesterol AND Momordica charantia;Biochemical analysis of the crude extract of Momordica charantia (L.).
25520930;2014;na;cholesterol AND Momordica charantia;Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis.
25153878;2014 Aug 21;na;cholesterol AND Momordica charantia;Anti-inflammatory effect of Momordica charantia in sepsis mice.
24523491;2014 Apr;na;cholesterol AND Momordica charantia;Bitter gourd inhibits the development of obesity-associated fatty liver in C57BL/6 mice fed a high-fat diet.
23833751;2013 Apr;na;cholesterol AND Momordica charantia;Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system.
23827133;2013 Jul;na;cholesterol AND Momordica charantia;The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver.
23053765;2013 Jun;na;cholesterol AND Momordica charantia;In vitro toxicity and antidiabetic activity of a newly developed polyherbal formulation (MAC-ST/001) in streptozotocin-induced diabetic Wistar rats.
22457205;2012 May;na;cholesterol AND Momordica charantia;Mechanisms underlying decreased hepatic triacylglycerol and cholesterol by dietary bitter melon extract in the rat.
22439816;2012 Oct;na;cholesterol AND Momordica charantia;PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of alpha-momorcharin in vivo.
22297232;2012 Jan;na;cholesterol AND Momordica charantia;Synergic effects of bitter melon and beta-Glucan composition on STZ-induced rat diabetes and its complications.
21930012;2011 Oct;na;cholesterol AND Momordica charantia;Niacin-bound chromium increases life span in Zucker Fatty Rats.
21913530;2010 Oct-Dec;na;cholesterol AND Momordica charantia;Effect of methanolic seed extract of Momordica charantia on body weight and serum cholesterol level of male Sprague-Dawley rats.
21814874;2012 Jun;na;cholesterol AND Momordica charantia;Comparative study of hypocholesterolemic and hypolipidemic effects of conjugated linolenic acid isomers against induced biochemical perturbations and aberration in erythrocyte membrane fluidity.
21791551;2011 Oct;na;cholesterol AND Momordica charantia;Dietary kakrol (Momordica dioica Roxb.) flesh inhibits triacylglycerol absorption and lowers the risk for development of fatty liver in rats.
21128828;2011 Jan-Feb;na;cholesterol AND Momordica charantia;Dietary bitter melon seed increases peroxisome proliferator-activated receptor-gamma gene expression in adipose tissue, down-regulates the nuclear factor-kappaB expression, and alleviates the symptoms associated with metabolic syndrome.
20939353;2010 Aug;na;cholesterol AND Momordica charantia;[Mineral elements analysis of Momordica charantiap seeds by ICP-AES and fatty acid profile identification of seed oil by GC-MS].
19761040;2009 Jul;na;cholesterol AND Momordica charantia;Antihyperglycemic, antihyperlipidemic and antioxidant effects of Dihar, a polyherbal ayurvedic formulation in streptozotocin induced diabetic rats.
19362455;2009 May;na;cholesterol AND Momordica charantia;Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
19216552;2009 Mar 11;na;cholesterol AND Momordica charantia;Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk-soymilk supplemented with Momordica charantia.
17942003;2008 Apr;na;cholesterol AND Momordica charantia;Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats.
22444893;2007 Oct;na;cholesterol AND Momordica charantia;Bioactivity of phytochemicals in some lesser-known plants and their effects and potential applications in livestock and aquaculture production systems.
17892543;2007 Sep 24;na;cholesterol AND Momordica charantia;An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract.
17493509;2007 Jun;na;cholesterol AND Momordica charantia;The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
17040567;2006 Oct 13;na;cholesterol AND Momordica charantia;Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus.
16940700;2006 Jun;na;cholesterol AND Momordica charantia;Potassium excretion in healthy Japanese women was increased by a dietary intervention utilizing home-parcel delivery of Okinawan vegetables.
16815658;2006 Nov 24;na;cholesterol AND Momordica charantia;Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats.
16196458;2005;na;cholesterol AND Momordica charantia;Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet.
16106394;2005 May;na;cholesterol AND Momordica charantia;Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus.
15975176;2005 May;na;cholesterol AND Momordica charantia;Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines.
15724444;2005 Jan;na;cholesterol AND Momordica charantia;Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats.
15597317;2004 Nov;na;cholesterol AND Momordica charantia;Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats.
15527066;2004 Aug;na;cholesterol AND Momordica charantia;The effects of bitter melon (Momordica charantia) extracts on serum and liver lipid parameters in hamsters fed cholesterol-free and cholesterol-enriched diets.
15120448;2004 Apr;na;cholesterol AND Momordica charantia;The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats.
14974734;2003 Dec;na;cholesterol AND Momordica charantia;Bitter melon malt vinegar increases daily energy turnover in rats.
11747298;2001 Dec 15;na;cholesterol AND Momordica charantia;Dietary effects of bitter gourd oil on blood and liver lipids of rats.
11269887;2001 Mar;na;cholesterol AND Momordica charantia;Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats.
11113993;2000 Dec;na;cholesterol AND Momordica charantia;Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia.
10967491;2000 Sep;na;cholesterol AND Momordica charantia;Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.
10102236;1999 Feb;na;cholesterol AND Momordica charantia;Dietary effects of conjugated octadecatrienoic fatty acid (9 cis, 11 trans, 13 trans) levels on blood lipids and nonenzymatic in vitro lipid peroxidation in rats.
9812020;1998;na;cholesterol AND Momordica charantia;Nutritional characteristics of oil containing conjugated octadecatrienoic fatty acid.
9687077;1998 May;na;cholesterol AND Momordica charantia;Antispermatogenic and androgenic activities of Momordica charantia (Karela) in albino rats.
7477242;1995;na;cholesterol AND Momordica charantia;Effect of dietary intake of freeze dried bitter gourd (Momordica charantia) in streptozotocin induced diabetic rats.
8510714;1993;na;cholesterol AND Momordica charantia;Influence of bitter gourd (Momordica charantia) on growth and blood constituents in albino rats.
2777367;1989 Apr-Jun;na;cholesterol AND Momordica charantia;Effects of long term feeding of acetone extract of Momordica charantia (whole fruit powder) on alloxan diabetic albino rats.
29463104;2018;na;heart disease AND Momordica charantia;Momordica charantia Inhibits Inflammatory Responses in Murine Macrophages via Suppression of TAK1.
28962621;2017 Sep 29;na;heart disease AND Momordica charantia;The anti-adiposity effect of bitter melon seed oil is solely attributed to its fatty acid components.
28335529;2017 Mar 20;na;heart disease AND Momordica charantia;Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium.
28109806;2017 Apr;na;heart disease AND Momordica charantia;Momordica charantia polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the NF-kappaB signaling pathway.
25371774;2014;na;heart disease AND Momordica charantia;Protective effect of Momordica charantia fruit extract on hyperglycaemia-induced cardiac fibrosis.
21966327;2011;na;heart disease AND Momordica charantia;Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.
21731396;2011 Jan;na;heart disease AND Momordica charantia;Standardization of some herbal antidiabetic drugs in polyherbal formulation.
21128828;2011 Jan-Feb;na;heart disease AND Momordica charantia;Dietary bitter melon seed increases peroxisome proliferator-activated receptor-gamma gene expression in adipose tissue, down-regulates the nuclear factor-kappaB expression, and alleviates the symptoms associated with metabolic syndrome.
20103967;2010 Jan-Feb;na;heart disease AND Momordica charantia;A case of atrial fibrillation due to Momordica charantia (bitter melon).
17696480;2007 Sep 19;na;heart disease AND Momordica charantia;Oligomers of resveratrol and ferulic acid prepared by peroxidase-catalyzed oxidation and their protective effects on cardiac injury.
17693694;2006;na;heart disease AND Momordica charantia;Antioxidative effect of conjugated linolenic acid in diabetic and non-diabetic blood: an in vitro study.
17040567;2006 Oct 13;na;heart disease AND Momordica charantia;Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus.
16940700;2006 Jun;na;heart disease AND Momordica charantia;Potassium excretion in healthy Japanese women was increased by a dietary intervention utilizing home-parcel delivery of Okinawan vegetables.
31062632;2019 May 7;na;weight loss AND Momordica charantia;Alpha-momorcharin regulates cytokine expression and induces apoptosis in monocytes.
30627515;2018;na;weight loss AND Momordica charantia;Nephrotoxicity and highly active antiretroviral therapy: Mitigating action of Momordica charantia.
30600821;2019 Jan 22;na;weight loss AND Momordica charantia;Dietary wild bitter gourd displays selective androgen receptor modulator like activity and improves the muscle decline of orchidectomized mice.
27774692;2017 Feb;na;weight loss AND Momordica charantia;Isolation and partial characterization of 3 nontoxic d-galactose-specific isolectins from seeds of Momordica balsamina.
27538854;2016 Dec;na;weight loss AND Momordica charantia;(1)H NMR-based metabolic study reveals the improvements of bitter melon (Momordica charantia) on energy metabolism in diet-induced obese mouse.
26318666;2015 Nov;na;weight loss AND Momordica charantia;Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice.
23203059;2012 Nov 2;na;weight loss AND Momordica charantia;Effect of superfine grinding on antidiabetic activity of bitter melon powder.
22172326;2012 Jan 31;na;weight loss AND Momordica charantia;Alpha-momorcharin possessing high immunogenicity, immunotoxicity and hepatotoxicity in SD rats.
21966327;2011;na;weight loss AND Momordica charantia;Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.
21367579;2011 Jun;na;weight loss AND Momordica charantia;Polyphenols: planting the seeds of treatment for the metabolic syndrome.
20450027;2010 Jan-Mar;na;weight loss AND Momordica charantia;Effect of aqueous leaf extract of Momordica charantia on intestinal enzyme activities in diarrhoeagenic mice.
17693691;2006;na;weight loss AND Momordica charantia;Efficacy of application of vegetable seed oils as grain protectant against infestation by Callosobruchus chinensis and its effect on milling fractions and apparent degree of dehusking of legume-pulses.
29050491;2017;na;common cold AND Momordica charantia;Some antidiabetic medicinal plants used by traditional healers in Ado Ekiti, Nigeria.
26369926;2015 Sep 15;na;common cold AND Momordica charantia;An ethnobotanical survey of medicinal plants in Trinidad.
23692809;2014 Feb;na;common cold AND Momordica charantia;Antinociceptive and antiallodynic effects of Momordica charantia L. in tibial and sural nerve transection-induced neuropathic pain in rats.
28120728;2017;na;vision AND Momordica charantia;Momordicacharantia: A New Strategic Vision to Improve the Therapy of Endoplasmic Reticulum Stress.
30627515;2018;na;HIV AND Momordica charantia;Nephrotoxicity and highly active antiretroviral therapy: Mitigating action of Momordica charantia.
29932035;2019;na;HIV AND Momordica charantia;Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
27809255;2016 Oct 31;na;HIV AND Momordica charantia;Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity.
27459300;2016;na;HIV AND Momordica charantia;Expression of a Recombinant Anti-HIV and Anti-Tumor Protein, MAP30, in Nicotiana tobacum Hairy Roots: A pH-Stable and Thermophilic Antimicrobial Protein.
25681721;2015 Apr 10;na;HIV AND Momordica charantia;Zirconium phosphatidylcholine-based nanocapsules as an in vivo degradable drug delivery system of MAP30, a momordica anti-HIV protein.
25003606;2014;na;HIV AND Momordica charantia;A novel method for simultaneous production of two ribosome-inactivating proteins, alpha-MMC and MAP30, from Momordica charantia L.
26019499;2014 Jan 2;na;HIV AND Momordica charantia;Gene cloning and expression of MAP30 in Pichia pastoris.
24297707;2014 Mar;na;HIV AND Momordica charantia;Effect of alpha, beta momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines.
22802682;2012;na;HIV AND Momordica charantia;Preparation of an antitumor and antivirus agent: chemical modification of alpha-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
23964459;2012 Jan;na;HIV AND Momordica charantia;Antimicrobial, antioxidant activities and total phenolic content of Thai medicinal plants used to treat HIV patients.
21568930;2011 Jul;na;HIV AND Momordica charantia;Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties.
19747115;2009 Dec;na;HIV AND Momordica charantia;Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy.
19744549;2009 Dec 10;na;HIV AND Momordica charantia;Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPAR gamma and PI3K.
19041990;2009 Jan;na;HIV AND Momordica charantia;Kuguacins F-S, cucurbitane triterpenoids from Momordica charantia.
18751697;2008 Dec;na;HIV AND Momordica charantia;Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus.
18246454;2008 May;na;HIV AND Momordica charantia;Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells.
18045630;2008 Feb;na;HIV AND Momordica charantia;Trinorcucurbitane and cucurbitane triterpenoids from the roots of Momordica charantia.
17567143;2007 Jul 11;na;HIV AND Momordica charantia;Effects of processing methods on the proximate composition and momordicosides K and L content of bitter melon vegetable.
16847441;2006 Aug;na;HIV AND Momordica charantia;Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.
15182917;2004 Jul;na;HIV AND Momordica charantia;Pharmacological actions and potential uses of Momordica charantia: a review.
11906182;2002 Mar 29;na;HIV AND Momordica charantia;Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII.
11582548;2001 Oct;na;HIV AND Momordica charantia;Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases.
11573962;2001 Oct 5;na;HIV AND Momordica charantia;Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
11458453;2001 Jun;na;HIV AND Momordica charantia;HIV inhibitor from Thai bitter gourd.
10767416;2000 Apr 14;na;HIV AND Momordica charantia;The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase.
10739256;2000 Jan;na;HIV AND Momordica charantia;Anti-HIV and anti-tumor protein MAP30, a 30 kDa single-strand type-I RIP, shares similar secondary structure and beta-sheet topology with the A chain of ricin, a type-II RIP.
10625418;2000 Jan;na;HIV AND Momordica charantia;The food of sweet and bitter fancy.
10571185;1999 Nov 12;na;HIV AND Momordica charantia;Solution structure of anti-HIV-1 and anti-tumor protein MAP30: structural insights into its multiple functions.
10521111;1999 Oct;na;HIV AND Momordica charantia;The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
10471373;1999 Sep 7;na;HIV AND Momordica charantia;Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active.
10452099;1999 Mar;na;HIV AND Momordica charantia;Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
9367169;1997 Oct 20;na;HIV AND Momordica charantia;Antigenic determination fragments of alpha-momorcharin.
8645280;1996 Feb 27;na;HIV AND Momordica charantia;The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro.
7568024;1995 Sep 12;na;HIV AND Momordica charantia;Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
7665070;1995 Aug 19;na;HIV AND Momordica charantia;Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
7695636;1995 Mar 17;na;HIV AND Momordica charantia;Potentiation of anti-HIV activity of anti-inflammatory drugs, dexamethasone and indomethacin, by MAP30, the antiviral agent from bitter melon.
21559696;1994 Nov;na;HIV AND Momordica charantia;In-vitro antitumor-activity of the plant ribosome-inactivating proteins map-30 and gap-31.
1397965;1992 Jul;na;HIV AND Momordica charantia;Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from Cucurbitaceae plants.
2001404;1991 Feb 16;na;HIV AND Momordica charantia;Cloning of the cDNA of alpha-momorcharin: a ribosome inactivating protein.
1699801;1990 Oct 15;na;HIV AND Momordica charantia;MAP 30: a new inhibitor of HIV-1 infection and replication.
26019499;2014 Jan 2;na;herpes AND Momordica charantia;Gene cloning and expression of MAP30 in Pichia pastoris.
22802682;2012;na;herpes AND Momordica charantia;Preparation of an antitumor and antivirus agent: chemical modification of alpha-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
15588650;2005 Jan 4;na;herpes AND Momordica charantia;Ethnomedicinal uses of Momordicacharantia (Cucurbitaceae) in Togo and relation to its phytochemistry and biological activity.
11573962;2001 Oct 5;na;herpes AND Momordica charantia;Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
10521111;1999 Oct;na;herpes AND Momordica charantia;The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
8645280;1996 Feb 27;na;herpes AND Momordica charantia;The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro.
6284092;1982;na;herpes AND Momordica charantia;Effect of ribosome-inactivating proteins on virus-infected cells. Inhibition of virus multiplication and of protein synthesis.
29932035;2019;na;aging AND Momordica charantia;Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
29765490;2018;na;aging AND Momordica charantia;Antiaging of Cucurbitane Glycosides from Fruits of Momordica charantia L.
29655703;2018 Mar 15;na;aging AND Momordica charantia;The effects of wild bitter gourd fruit extracts on ICAM-1 expression in pulmonary epithelial cells of C57BL/6J mice and microRNA-221/222 knockout mice: Involvement of the miR-221/-222/PI3K/AKT/NF-kappaB pathway.
21930012;2011 Oct;na;aging AND Momordica charantia;Niacin-bound chromium increases life span in Zucker Fatty Rats.
15236800;2004;na;aging AND Momordica charantia;Does bitter melon contain an activator of AMP-activated kinase?
15139192;2004 Jan;na;aging AND Momordica charantia;[Effects of zinc and boron nutrition on balsam pear (Momordica charantia) yield and quality, and polyamines, hormone, and senescence of its leaves].
14974734;2003 Dec;na;aging AND Momordica charantia;Bitter melon malt vinegar increases daily energy turnover in rats.
30360709;2019;na;wound( healing) AND Momordica charantia;Molecular Concept of Diabetic Wound Healing: Effective Role of Herbal Remedies.
30318521;2018 Nov 14;na;wound( healing) AND Momordica charantia;Momordica charantia extracts protect against inhibition of endothelial angiogenesis by advanced glycation endproducts in vitro.
29556310;2018 Apr;na;wound( healing) AND Momordica charantia;MAP30 promotes apoptosis of U251 and U87 cells by suppressing the LGR5 and Wnt/beta-catenin signaling pathway, and enhancing Smac expression.
27984270;2017 Jan;na;wound( healing) AND Momordica charantia;Bitter Melon Extract Promotes Granulation Tissue Growth and Angiogenesis in the Diabetic Wound.
26431827;2015 Dec;na;wound( healing) AND Momordica charantia;Topical application of olive oil macerate of Momordica charantia L. promotes healing of excisional and incisional wounds in rat buccal mucosa.
25139598;2014 Aug;na;wound( healing) AND Momordica charantia;Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-beta expression.
22812507;2014 Aug;na;wound( healing) AND Momordica charantia;The beneficial effects of Momordica charantia (bitter gourd) on wound healing of rabbit skin.
21966327;2011;na;wound( healing) AND Momordica charantia;Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.
20931161;2010;na;wound( healing) AND Momordica charantia;Wound healing in diabetes mellitus: traditional treatment modalities.
19508570;2009 Oct;na;wound( healing) AND Momordica charantia;The effect of topical extract of Momordica charantia (bitter gourd) on wound healing in nondiabetic rats and in rats with diabetes induced by streptozotocin.
19223201;2009 Apr;na;wound( healing) AND Momordica charantia;Induction of hepatocyte growth factor production in human dermal fibroblasts and their proliferation by the extract of bitter melon pulp.
17317652;2006;na;wound( healing) AND Momordica charantia;Wound-healing property of Momordica charantia L. fruit powder.
26369926;2015 Sep 15;na;coughing AND Momordica charantia;An ethnobotanical survey of medicinal plants in Trinidad.
21939522;2011 Sep 22;na;coughing AND Momordica charantia;Folk medicine in the northern coast of Colombia: an overview.
29655677;2018 Mar 15;na;liver problems AND Momordica charantia;An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
29574244;2018 Apr;na;infections AND Momordica charantia;Alpha-momorcharin enhances Tobacco mosaic virus resistance in tobacco(NN) by manipulating jasmonic acid-salicylic acid crosstalk.
28812026;2017;na;infections AND Momordica charantia;Evidence of Immunosuppressive and Th2 Immune Polarizing Effects of Antidiabetic Momordica charantia Fruit Juice.
28503051;2017 Jan-Jun;na;infections AND Momordica charantia;An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia.
28389897;2017 May;na;infections AND Momordica charantia;Novel purification method and antibiotic activity of recombinant Momordica charantia MAP30.
27881976;2016;na;infections AND Momordica charantia;The Roles of Alpha-Momorcharin and Jasmonic Acid in Modulating the Response of Momordica charantia to Cucumber Mosaic Virus.
27459300;2016;na;infections AND Momordica charantia;Expression of a Recombinant Anti-HIV and Anti-Tumor Protein, MAP30, in Nicotiana tobacum Hairy Roots: A pH-Stable and Thermophilic Antimicrobial Protein.
27400705;2016 Aug;na;infections AND Momordica charantia;Transmission of Squash vein yellowing virus to and From Cucurbit Weeds and Effects on Sweetpotato Whitefly (Hemiptera: Aleyrodidae) Behavior.
27058519;2016 Apr 6;na;infections AND Momordica charantia;Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation.
26924564;2016 May 26;na;infections AND Momordica charantia;Medicinal plants used in the traditional management of diabetes and its sequelae in Central America: A review.
26718290;2015 Nov 1;na;infections AND Momordica charantia;Antimicrobial Potential of Momordica charantia L. against Multiresistant Standard Species and Clinical Isolates.
26459126;2015 Sep;na;infections AND Momordica charantia;[Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus III. Momordica (Momordica charantia)].
26369926;2015 Sep 15;na;infections AND Momordica charantia;An ethnobotanical survey of medicinal plants in Trinidad.
25639923;2016 Jan-Feb;na;infections AND Momordica charantia;Constitutive expression of McCHIT1-PAT enhances resistance to rice blast and herbicide, but does not affect grain yield in transgenic glutinous rice.
30703922;2014 Dec;na;infections AND Momordica charantia;First Report of Citrus yellow vein clearing virus on Lemon in Yunnan, China.
25183066;2014 May;na;infections AND Momordica charantia;Screening, isolation and optimization of anti-white spot syndrome virus drug derived from terrestrial plants.
30699625;2014 Sep;na;infections AND Momordica charantia;First Report of Pseudoperonospora cubensis Causing Downy Mildew on Momordica balsamina and M. charantia in North Carolina.
25153878;2014 Aug 21;na;infections AND Momordica charantia;Anti-inflammatory effect of Momordica charantia in sepsis mice.
24722532;2014;na;infections AND Momordica charantia;Fusion of protegrin-1 and plectasin to MAP30 shows significant inhibition activity against dengue virus replication.
26019499;2014 Jan 2;na;infections AND Momordica charantia;Gene cloning and expression of MAP30 in Pichia pastoris.
23229317;2013 Feb;na;infections AND Momordica charantia;Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection.
22953813;2012 Dec 1;na;infections AND Momordica charantia;Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation.
23964459;2012 Jan;na;infections AND Momordica charantia;Antimicrobial, antioxidant activities and total phenolic content of Thai medicinal plants used to treat HIV patients.
21293936;2011 Jul;na;infections AND Momordica charantia;Inhibition of proliferation by agricultural plant extracts in seven human adult T-cell leukaemia (ATL)-related cell lines.
20924621;2010 Nov;na;infections AND Momordica charantia;Complete nucleotide sequences of a distinct bipartite begomovirus, bitter gourd yellow vein virus, infecting Momordica charantia.
30754274;2010 Feb;na;infections AND Momordica charantia;First Report of Tomato leaf curl Palampur virus on Bitter Gourd in Pakistan.
19747115;2009 Dec;na;infections AND Momordica charantia;Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy.
30764122;2009 Feb;na;infections AND Momordica charantia;Occurrence of Cucumber green mottle mosaic virus on Cucurbitaceous Plants in China.
30769530;2008 Jul;na;infections AND Momordica charantia;Squash vein yellowing virus Detection Using Nested Polymerase Chain Reaction Demonstrates that the Cucurbit Weed Momordica charantia Is a Reservoir Host.
22436096;2008;na;infections AND Momordica charantia;Tropical American plants in the treatment of infectious diseases.
18069905;2007 Dec;na;infections AND Momordica charantia;Momordica charantia (bitter melon). Monograph.
30780759;2007 Nov;na;infections AND Momordica charantia;Momordica charantia is a Weed Host Reservoir for Papaya ringspot virus Type P in Jamaica.
17158106;2007;na;infections AND Momordica charantia;The effect of silicon on the infection by and spread of Pythium aphanidermatum in single roots of tomato and bitter gourd.
15942138;2005 May;na;infections AND Momordica charantia;Induction of interferon-gamma (IFN-gamma) and T helper 1 (Th1) immune response by bitter gourd extract.
15182917;2004 Jul;na;infections AND Momordica charantia;Pharmacological actions and potential uses of Momordica charantia: a review.
12080730;1999;na;infections AND Momordica charantia;[Momordica charantia proteins against coxsackievirus B3 infection in vitro].
22557016;2001 Apr;na;infections AND Momordica charantia;Effect of karela (momordica charantia) powder in jarah (scabies).
10737198;2000 Feb;na;infections AND Momordica charantia;Cloning and expression of the Momordica charantia trypsin inhibitor II gene in silkworm by using a baculovirus vector.
10521111;1999 Oct;na;infections AND Momordica charantia;The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
8966309;1996 Sep-Oct;na;infections AND Momordica charantia;[Effect of Momordica charantia L. in mice infected with Plasmodium berghei].
8645280;1996 Feb 27;na;infections AND Momordica charantia;The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro.
7568024;1995 Sep 12;na;infections AND Momordica charantia;Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
7665070;1995 Aug 19;na;infections AND Momordica charantia;Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
21559696;1994 Nov;na;infections AND Momordica charantia;In-vitro antitumor-activity of the plant ribosome-inactivating proteins map-30 and gap-31.
1699801;1990 Oct 15;na;infections AND Momordica charantia;MAP 30: a new inhibitor of HIV-1 infection and replication.
26098998;2015 Aug;na;acne AND Momordica charantia;Inhibitory effects of wild bitter melon leaf extract on Propionibacterium acnes-induced skin inflammation in mice and cytokine production in vitro.
15182917;2004 Jul;na;psoriasis AND Momordica charantia;Pharmacological actions and potential uses of Momordica charantia: a review.
29932035;2019;na;ageing AND Momordica charantia;Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
29765490;2018;na;ageing AND Momordica charantia;Antiaging of Cucurbitane Glycosides from Fruits of Momordica charantia L.
29655703;2018 Mar 15;na;ageing AND Momordica charantia;The effects of wild bitter gourd fruit extracts on ICAM-1 expression in pulmonary epithelial cells of C57BL/6J mice and microRNA-221/222 knockout mice: Involvement of the miR-221/-222/PI3K/AKT/NF-kappaB pathway.
24637239;2014 Jun 1;na;ageing AND Momordica charantia;Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia.
21930012;2011 Oct;na;ageing AND Momordica charantia;Niacin-bound chromium increases life span in Zucker Fatty Rats.
20717728;2010 Sep;na;ageing AND Momordica charantia;Screening of dried plant seed extracts for adiponectin production activity and tumor necrosis factor-alpha inhibitory activity on 3T3-L1 adipocytes.
16261524;2005 Oct;na;ageing AND Momordica charantia;Antioxidant activity of five vegetables traditionally consumed by South-Asian migrants in Bradford, Yorkshire, UK.
15236800;2004;na;ageing AND Momordica charantia;Does bitter melon contain an activator of AMP-activated kinase?
15139192;2004 Jan;na;ageing AND Momordica charantia;[Effects of zinc and boron nutrition on balsam pear (Momordica charantia) yield and quality, and polyamines, hormone, and senescence of its leaves].
14974734;2003 Dec;na;ageing AND Momordica charantia;Bitter melon malt vinegar increases daily energy turnover in rats.
27774692;2017 Feb;na;bladder AND Momordica charantia;Isolation and partial characterization of 3 nontoxic d-galactose-specific isolectins from seeds of Momordica balsamina.
25517785;2016 Jun;na;bladder AND Momordica charantia;Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells.
15182917;2004 Jul;na;bladder AND Momordica charantia;Pharmacological actions and potential uses of Momordica charantia: a review.
